###begin article-title 0
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
MECP2 genomic structure and function: insights from ENCODE
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 459 464 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 708 713 708 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 538 543 <span type="species:ncbi:9606">human</span>
MECP2, a relatively small gene located in the human X chromosome, was initially described with three exons transcribing RNA from which the protein MeCP2 was translated. It is now known to have four exons from which two isoforms are translated; however, there is also evidence of additional functional genomic structures within MECP2, including exons potentially transcribing non-coding RNAs. Accompanying the recognition of a higher level of intricacy within MECP2 has been a recent surge of knowledge about the structure and function of human genes more generally, to the extent that the definition of a gene is being revisited. It is timely now to review the published and novel functional elements within MECP2, which is proving to have a complexity far greater than was previously thought.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin title 4
Anatomy of a typical gene
###end title 4
###begin p 5
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
To perform their biological role, most well-characterized genes are expressed as protein, although it is now recognized that genes also transcribe a diverse array of non-coding RNAs (1). A typical eukaryotic gene, in addition to coding regions and protein domains, has a number of functional elements that play roles in transcription, post-transcriptional modification and translation. Exons, introns and 5'- and 3'-untranslated regions (UTRs) define the 'skeleton' of the gene, but a gene is also associated with sequences influencing splicing, regulatory elements such as promoters, enhancers, suppressors and CpG islands, at least one polyadenylation signal in the 3'-UTR, and transcription and translation initiation and termination sites. In addition to recognized functional elements, many genes also contain blocks of genomic sequence deep within introns that are highly conserved across species. The preservation of these sequence blocks strongly suggests that they have important functions that are yet to be defined.
###end p 5
###begin title 6
Upgraded concept of a eukaryotic gene
###end title 6
###begin p 7
###xml 279 282 279 282 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enc</underline>
###xml 293 294 293 294 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</underline>
###xml 296 297 296 297 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</underline>
###xml 300 301 300 301 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</underline>
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 466 471 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1069 1070 1057 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 385 390 <span type="species:ncbi:9606">human</span>
Until recently, insights into the roles of the multiple components within a gene, particularly the many sequence-specific functional elements in non-coding areas, have been limited. This is now changing quickly with many new insights emerging from the pilot project phase of the Encyclopaedia Of DNA Elements (ENCODE) project (2). ENCODE aims to produce a functional annotation of the human genome, beginning with a targeted approximately1% of the genome, including MECP2, for the pilot project. ENCODE is generating a vast quantity of new information about the transcriptional profiles of sequences within the targeted regions in different tissues and cell lines. The ENCODE output is also defining regions likely to contain functional regulatory elements based on features of chromatin structure, such as histone modifications and DNase I hypersensitivity sites, as well as binding sites of regulatory proteins. Measures of the extent of evolutionary conservation and secondary-structure predictions also help to highlight regions likely to be functionally relevant (2).
###end p 7
###begin p 8
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 280 290 280 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 690 691 690 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1214 1215 1214 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 1216 1217 1216 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1218 1219 1218 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1245 1246 1245 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1820 1821 1820 1821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
The ENCODE findings have provoked a fundamental reassessment of the concept of a gene (3,4). The term 'gene' was first coined by Johannsen in 1909 (5) to encapsulate Gregor Mendel's notion of a unit of heredity. Prompted particularly by studies of the segregation of mutations in Drosophila, which gave rise to the hypothesis that genes are structured as discrete elements organized in a linear array (6), the concept of a gene as a calculating unit transformed over time to the notion of a material unit with both structure and function. Recognition that gene mutations may cause inborn errors of metabolism strengthened the idea of a gene as a functional unit, or 'one gene, one enzyme' (7). The concept of a gene being a blueprint for a protein was strengthened in the 1950s when it was demonstrated that heritable information is stored in DNA and the 'central dogma' was developed to provide the crucial link between the physical structure of a gene within DNA and its functional protein products. In the last decade the view of genes as discrete, linearly arranged loci that generally encode a protein has evolved further with ongoing revelations regarding the structure, organization and functions of genes (3,4,8). Now ENCODE and others (9) have demonstrated that transcription is far more extensive than previously anticipated. Transcripts from the same and opposite strands often overlap, making it difficult to define discrete boundaries separating genes from one another. Furthermore, many novel transcribed regions have been detected in intergenic and intronic sequences. Recognition that many newly identified transcripts, including those from protein-coding loci, have tissue-specific expression but limited coding potential has spawned the now fast-growing interest in regulatory non-protein-coding RNAs (2).
###end p 8
###begin p 9
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 121 129 121 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 320 325 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 755 756 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 761 770 761 770 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 834 840 834 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2.</italic>
###xml 950 955 950 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1146 1148 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B83">83</xref>
###xml 770 1303 770 1303 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="10">ENCODE data reveals increased transcriptional complexity within <italic>MECP2.</italic> This screenshot from the March 2006 assembly of the UCSC Genome Browser (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>) compares the previously annotated <italic>MECP2</italic> gene structure (RefSeq-annotated genes) with the GENCODE annotation (v3.1, March 2007). The tracks &#8216;GENCODE RACEfrags&#8217; show the mapped locations of 5&#8242;-RACE products from a range of tissues (<xref ref-type="bibr" rid="B83">83</xref>). Also displayed is the Affymetrix data representing the genomic source and relative abundance of RNA transcripts detected in the cytoplasm of HeLa cells.</p>
###xml 770 1303 770 1303 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="10">ENCODE data reveals increased transcriptional complexity within <italic>MECP2.</italic> This screenshot from the March 2006 assembly of the UCSC Genome Browser (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>) compares the previously annotated <italic>MECP2</italic> gene structure (RefSeq-annotated genes) with the GENCODE annotation (v3.1, March 2007). The tracks &#8216;GENCODE RACEfrags&#8217; show the mapped locations of 5&#8242;-RACE products from a range of tissues (<xref ref-type="bibr" rid="B83">83</xref>). Also displayed is the Affymetrix data representing the genomic source and relative abundance of RNA transcripts detected in the cytoplasm of HeLa cells.</p></caption>
###xml 1303 1303 1303 1303 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn591f1"/>
###xml 761 1303 761 1303 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="10">ENCODE data reveals increased transcriptional complexity within <italic>MECP2.</italic> This screenshot from the March 2006 assembly of the UCSC Genome Browser (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>) compares the previously annotated <italic>MECP2</italic> gene structure (RefSeq-annotated genes) with the GENCODE annotation (v3.1, March 2007). The tracks &#8216;GENCODE RACEfrags&#8217; show the mapped locations of 5&#8242;-RACE products from a range of tissues (<xref ref-type="bibr" rid="B83">83</xref>). Also displayed is the Affymetrix data representing the genomic source and relative abundance of RNA transcripts detected in the cytoplasm of HeLa cells.</p></caption><graphic xlink:href="gkn591f1"/></fig>
Novel features identified within MECP2 by the pilot phase of ENCODE help illustrate these emerging insights. As shown in Figure 1, 5' rapid amplification of cDNA ends (5'-RACE) has extended the known 5'-terminal of MECP2 further upstream, and also identified transcripts that connect downstream genes with the 3'-UTR of MECP2, or with genes upstream of MECP2 (10; ). Novel transcribed regions identified by 5'-RACE appear to be expressed in a tissue-specific manner, which raises the spectre of a diversity of previously unrecognized tissue-specific functions. Such findings across the ENCODE regions have prompted suggestions that a gene should be defined not at the DNA level, but rather at the level of its functional products, whether RNA or protein (3,4). Figure 1.ENCODE data reveals increased transcriptional complexity within MECP2. This screenshot from the March 2006 assembly of the UCSC Genome Browser () compares the previously annotated MECP2 gene structure (RefSeq-annotated genes) with the GENCODE annotation (v3.1, March 2007). The tracks 'GENCODE RACEfrags' show the mapped locations of 5'-RACE products from a range of tissues (83). Also displayed is the Affymetrix data representing the genomic source and relative abundance of RNA transcripts detected in the cytoplasm of HeLa cells.
###end p 9
###begin p 10
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2.</italic>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B83">83</xref>
ENCODE data reveals increased transcriptional complexity within MECP2. This screenshot from the March 2006 assembly of the UCSC Genome Browser () compares the previously annotated MECP2 gene structure (RefSeq-annotated genes) with the GENCODE annotation (v3.1, March 2007). The tracks 'GENCODE RACEfrags' show the mapped locations of 5'-RACE products from a range of tissues (83). Also displayed is the Affymetrix data representing the genomic source and relative abundance of RNA transcripts detected in the cytoplasm of HeLa cells.
###end p 10
###begin title 11
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
MECP2 IN RELATION TO OTHER HUMAN GENES
###end title 11
###begin p 12
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 521 526 521 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13 B14 B15">13&#8211;15</xref>
###xml 560 565 560 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 693 698 693 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 758 763 758 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1032 1034 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1035 1037 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1038 1040 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1041 1043 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1067 1072 1067 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 882 887 <span type="species:ncbi:9606">human</span>
There is great diversity in the size and complexity of human genes. The dystrophin gene, for example, has 79 exons spanning over 2.3 million base pairs (11). To begin examining the structural features of a gene using the example of dystrophin would indeed be a daunting task. By contrast, the MECP2 gene with only four published exons (12) offers a more tractable opportunity to summarize the currently discernible functional components of a multi-exonic gene. In addition, as an X-linked gene subject to X inactivation (13-15), the impact of mutations within MECP2 is generally easier to characterize than mutations in most autosomal genes. It is becoming increasingly evident, however, that MECP2 has a higher level of complexity than originally believed. MECP2 has some remarkable features, most notably the extent of its 3'-UTR (12,16), which is one of the longest known in the human genome. It also contains several polyadenylation signals that give rise to transcripts of different lengths with different expression patterns (12,14,16,17). The second intron of MECP2, traversing almost 60 000 nucleotides, is atypically long and contains several regions with notable evolutionary conservation (12; ). Alternative transcripts in addition to those reported in the literature have been identified by the ENCODE Consortium and are now being deposited in genome databases.
###end p 12
###begin p 13
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 426 431 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 483 488 <span type="species:ncbi:9606">human</span>
The emerging details from ENCODE are yielding more insight into the function and regulation of MECP2 expression, as well as pinpointing genomic sites where previously unrecognized disease-causing mutations could occur. For these reasons it is timely to conduct a detailed reassessment of the MECP2 genomic sequence. We integrate here the data made available by the ENCODE project with the previously published features of the MECP2 gene. Insights gathered from this relatively small human gene have the potential to yield lessons that may have relevance to larger, more complex genes.
###end p 13
###begin title 14
BIOLOGICAL FUNCTIONS OF MECP2
###end title 14
###begin p 15
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 905 912 905 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 1126 1131 1126 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27 B28 B29">27&#8211;29</xref>
###xml 1272 1274 1272 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1275 1277 1275 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1458 1460 1458 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1525 1533 1525 1533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1779 1781 1779 1781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1801 1803 1801 1803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1815 1817 1815 1817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1945 1947 1945 1947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1982 1990 1982 1990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2111 2119 2111 2119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2175 2180 2175 2180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35 B36 B37">35&#8211;37</xref>
###xml 2406 2408 2406 2408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 2549 2551 2549 2551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 2645 2649 2645 2649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlx5</italic>
###xml 2654 2658 2654 2658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlx6</italic>
###xml 2714 2720 2714 2720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2722 2724 2722 2724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 2763 2767 2763 2767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlx5</italic>
###xml 2772 2776 2772 2776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlx6</italic>
###xml 2885 2890 2885 2890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 3035 3039 3035 3039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlx5</italic>
###xml 3044 3048 3044 3048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlx6</italic>
###xml 3109 3114 3109 3114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 3240 3248 3240 3248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 3257 3263 3257 3263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 3265 3267 3265 3267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 3352 3356 3352 3356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlx5</italic>
###xml 3361 3365 3361 3365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlx6</italic>
###xml 3391 3396 3391 3396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 3528 3537 3528 3537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLX5/DLX6</italic>
###xml 3624 3626 3624 3626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 3629 3637 3629 3637 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1.</label>
###xml 3637 3655 3637 3655 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="16">MeCP2 target genes</p>
###xml 3637 3655 3637 3655 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="16">MeCP2 target genes</p></caption>
###xml 3655 3659 3655 3659 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Gene</th>
###xml 3659 3667 3659 3667 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Function</th>
###xml 3667 3677 3667 3677 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">References</th>
###xml 3655 3677 3655 3677 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Function</th><th rowspan="1" colspan="1">References</th></tr>
###xml 3655 3677 3655 3677 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Function</th><th rowspan="1" colspan="1">References</th></tr></thead>
###xml 3677 3685 3677 3685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">xHairy2a</italic>
###xml 3677 3685 3677 3685 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>xHairy2a</italic></td>
###xml 3685 3703 3685 3703 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Neuronal repressor</td>
###xml 3704 3706 3704 3706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 3703 3707 3703 3707 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B56">56</xref>)</td>
###xml 3677 3707 3677 3707 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>xHairy2a</italic></td><td rowspan="1" colspan="1">Neuronal repressor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B56">56</xref>)</td></tr>
###xml 3707 3716 3707 3716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BDNF/Bdnf</italic>
###xml 3707 3716 3707 3716 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>BDNF/Bdnf</italic></td>
###xml 3716 3738 3716 3738 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Long term potentiation</td>
###xml 3739 3741 3739 3741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B81">81</xref>
###xml 3742 3744 3742 3744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B90">90</xref>
###xml 3738 3745 3738 3745 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B81">81</xref>,<xref ref-type="bibr" rid="B90">90</xref>)</td>
###xml 3707 3745 3707 3745 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>BDNF/Bdnf</italic></td><td rowspan="1" colspan="1">Long term potentiation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B81">81</xref>,<xref ref-type="bibr" rid="B90">90</xref>)</td></tr>
###xml 3745 3749 3745 3749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2</italic>
###xml 3745 3749 3745 3749 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>IGF2</italic></td>
###xml 3749 3767 3749 3767 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cell proliferation</td>
###xml 3768 3770 3768 3770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B91">91</xref>
###xml 3767 3771 3767 3771 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B91">91</xref>)</td>
###xml 3745 3771 3745 3771 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>IGF2</italic></td><td rowspan="1" colspan="1">Cell proliferation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B91">91</xref>)</td></tr>
###xml 3771 3775 3771 3775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MPP1</italic>
###xml 3771 3775 3771 3775 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>MPP1</italic></td>
###xml 3775 3794 3775 3794 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Signal transduction</td>
###xml 3795 3797 3795 3797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B91">91</xref>
###xml 3794 3798 3794 3798 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B91">91</xref>)</td>
###xml 3771 3798 3771 3798 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>MPP1</italic></td><td rowspan="1" colspan="1">Signal transduction</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B91">91</xref>)</td></tr>
###xml 3798 3809 3798 3809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBE3A/Ube3a</italic>
###xml 3798 3809 3798 3809 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>UBE3A/Ube3a</italic></td>
###xml 3809 3820 3809 3820 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Proteolysis</td>
###xml 3821 3823 3821 3823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B92">92</xref>
###xml 3824 3826 3824 3826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B93">93</xref>
###xml 3820 3827 3820 3827 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B92">92</xref>,<xref ref-type="bibr" rid="B93">93</xref>)</td>
###xml 3798 3827 3798 3827 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>UBE3A/Ube3a</italic></td><td rowspan="1" colspan="1">Proteolysis</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B92">92</xref>,<xref ref-type="bibr" rid="B93">93</xref>)</td></tr>
###xml 3827 3840 3827 3840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GABRB3/Gabrb3</italic>
###xml 3827 3840 3827 3840 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>GABRB3/Gabrb3</italic></td>
###xml 3840 3861 3840 3861 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GABA receptor subunit</td>
###xml 3862 3864 3862 3864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B92">92</xref>
###xml 3861 3865 3861 3865 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B92">92</xref>)</td>
###xml 3827 3865 3827 3865 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>GABRB3/Gabrb3</italic></td><td rowspan="1" colspan="1">GABA receptor subunit</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B92">92</xref>)</td></tr>
###xml 3865 3874 3865 3874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLX5/Dlx5</italic>
###xml 3865 3874 3865 3874 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>DLX5/Dlx5</italic></td>
###xml 3874 3894 3874 3894 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Transcription factor</td>
###xml 3895 3897 3895 3897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 3894 3898 3894 3898 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B40">40</xref>)</td>
###xml 3865 3898 3865 3898 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>DLX5/Dlx5</italic></td><td rowspan="1" colspan="1">Transcription factor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B40">40</xref>)</td></tr>
###xml 3898 3902 3898 3902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlx6</italic>
###xml 3898 3902 3898 3902 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>Dlx6</italic></td>
###xml 3902 3922 3902 3922 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Transcription factor</td>
###xml 3923 3925 3923 3925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 3926 3928 3926 3928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 3922 3929 3922 3929 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B40">40</xref>)</td>
###xml 3898 3929 3898 3929 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>Dlx6</italic></td><td rowspan="1" colspan="1">Transcription factor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B40">40</xref>)</td></tr>
###xml 3929 3934 3929 3934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fkbp5</italic>
###xml 3929 3934 3929 3934 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>Fkbp5</italic></td>
###xml 3934 3952 3934 3952 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Hormone signalling</td>
###xml 3953 3955 3953 3955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B94">94</xref>
###xml 3952 3956 3952 3956 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B94">94</xref>)</td>
###xml 3929 3956 3929 3956 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>Fkbp5</italic></td><td rowspan="1" colspan="1">Hormone signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B94">94</xref>)</td></tr>
###xml 3956 3960 3956 3960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sgk1</italic>
###xml 3956 3960 3956 3960 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>Sgk1</italic></td>
###xml 3960 3982 3960 3982 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ion channel activation</td>
###xml 3983 3985 3983 3985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B94">94</xref>
###xml 3982 3986 3982 3986 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B94">94</xref>)</td>
###xml 3956 3986 3956 3986 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>Sgk1</italic></td><td rowspan="1" colspan="1">Ion channel activation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B94">94</xref>)</td></tr>
###xml 3986 4011 3986 4011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ID1/Id1, ID2/Id2, ID3/Id3</italic>
###xml 3986 4011 3986 4011 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>ID1/Id1, ID2/Id2, ID3/Id3</italic></td>
###xml 4011 4037 4011 4037 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Transcriptional regulation</td>
###xml 4038 4040 4038 4040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B95">95</xref>
###xml 4037 4041 4037 4041 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B95">95</xref>)</td>
###xml 3986 4041 3986 4041 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>ID1/Id1, ID2/Id2, ID3/Id3</italic></td><td rowspan="1" colspan="1">Transcriptional regulation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B95">95</xref>)</td></tr>
###xml 4041 4047 4041 4047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Uqcrc1</italic>
###xml 4041 4047 4041 4047 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>Uqcrc1</italic></td>
###xml 4047 4088 4047 4088 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Mitochondrial respiratory complex subunit</td>
###xml 4089 4091 4089 4091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 4088 4092 4088 4092 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B59">59</xref>)</td>
###xml 4041 4092 4041 4092 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>Uqcrc1</italic></td><td rowspan="1" colspan="1">Mitochondrial respiratory complex subunit</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B59">59</xref>)</td></tr>
###xml 4092 4095 4092 4095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Crh</italic>
###xml 4092 4095 4092 4095 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>Crh</italic></td>
###xml 4095 4122 4095 4122 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Anxiety and stress response</td>
###xml 4123 4125 4123 4125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B96">96</xref>
###xml 4122 4126 4122 4126 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B96">96</xref>)</td>
###xml 4092 4126 4092 4126 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>Crh</italic></td><td rowspan="1" colspan="1">Anxiety and stress response</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B96">96</xref>)</td></tr>
###xml 4126 4139 4126 4139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP3/Igfbp3</italic>
###xml 4126 4139 4126 4139 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>IGFBP3/Igfbp3</italic></td>
###xml 4139 4157 4139 4157 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Hormone signalling</td>
###xml 4158 4160 4158 4160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B97">97</xref>
###xml 4157 4161 4157 4161 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B97">97</xref>)</td>
###xml 4126 4161 4126 4161 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>IGFBP3/Igfbp3</italic></td><td rowspan="1" colspan="1">Hormone signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B97">97</xref>)</td></tr>
###xml 4161 4172 4161 4172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FXYD1/Fxyd1</italic>
###xml 4161 4172 4161 4172 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>FXYD1/Fxyd1</italic></td>
###xml 4174 4175 4174 4175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 4177 4178 4177 4178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 4172 4194 4172 4194 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Na<sup>+</sup>/K<sup>+</sup>-ATPase activity</td>
###xml 4195 4197 4195 4197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B98">98</xref>
###xml 4198 4200 4198 4200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B99">99</xref>
###xml 4194 4201 4194 4201 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B99">99</xref>)</td>
###xml 4161 4201 4161 4201 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>FXYD1/Fxyd1</italic></td><td rowspan="1" colspan="1">Na<sup>+</sup>/K<sup>+</sup>-ATPase activity</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B99">99</xref>)</td></tr>
###xml 4201 4205 4201 4205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reln</italic>
###xml 4201 4205 4201 4205 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>Reln</italic></td>
###xml 4205 4220 4205 4220 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Cell signalling</td>
###xml 4221 4223 4221 4223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B99">99</xref>
###xml 4220 4224 4220 4224 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B99">99</xref>)</td>
###xml 4201 4224 4201 4224 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>Reln</italic></td><td rowspan="1" colspan="1">Cell signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B99">99</xref>)</td></tr>
###xml 4224 4233 4224 4233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gtl2/Meg3</italic>
###xml 4224 4233 4224 4233 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>Gtl2/Meg3</italic></td>
###xml 4233 4247 4233 4247 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Non-coding RNA</td>
###xml 4248 4250 4248 4250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B99">99</xref>
###xml 4247 4251 4247 4251 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B99">99</xref>)</td>
###xml 4224 4251 4224 4251 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>Gtl2/Meg3</italic></td><td rowspan="1" colspan="1">Non-coding RNA</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B99">99</xref>)</td></tr>
###xml 4251 4255 4251 4255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JUNB</italic>
###xml 4251 4255 4251 4255 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>JUNB</italic></td>
###xml 4255 4284 4255 4284 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Early response gene, Oncogene</td>
###xml 4285 4287 4285 4287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 4284 4288 4284 4288 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B42">42</xref>)</td>
###xml 4251 4288 4251 4288 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>JUNB</italic></td><td rowspan="1" colspan="1">Early response gene, Oncogene</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B42">42</xref>)</td></tr>
###xml 4288 4296 4288 4296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEH2A</italic>
###xml 4288 4296 4288 4296 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>RNASEH2A</italic></td>
###xml 4296 4340 4296 4340 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ribonucleotide cleavage from RNA&#8211;DNA complex</td>
###xml 4341 4343 4341 4343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 4340 4344 4340 4344 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B42">42</xref>)</td>
###xml 4288 4344 4288 4344 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>RNASEH2A</italic></td><td rowspan="1" colspan="1">Ribonucleotide cleavage from RNA&#8211;DNA complex</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B42">42</xref>)</td></tr>
###xml 4344 4347 4344 4347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sst</italic>
###xml 4344 4347 4344 4347 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>Sst</italic></td>
###xml 4347 4365 4347 4365 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Hormone signalling</td>
###xml 4366 4368 4366 4368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 4365 4369 4365 4369 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td>
###xml 4344 4369 4344 4369 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>Sst</italic></td><td rowspan="1" colspan="1">Hormone signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr>
###xml 4369 4374 4369 4374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oprk1</italic>
###xml 4369 4374 4369 4374 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>Oprk1</italic></td>
###xml 4374 4389 4374 4389 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Opioid receptor</td>
###xml 4390 4392 4390 4392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 4389 4393 4389 4393 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td>
###xml 4369 4393 4369 4393 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>Oprk1</italic></td><td rowspan="1" colspan="1">Opioid receptor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr>
###xml 4393 4397 4393 4397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gamt</italic>
###xml 4393 4397 4393 4397 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>Gamt</italic></td>
###xml 4397 4414 4397 4414 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Methyltransferase</td>
###xml 4415 4417 4415 4417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 4414 4418 4414 4418 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td>
###xml 4393 4418 4393 4418 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>Gamt</italic></td><td rowspan="1" colspan="1">Methyltransferase</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr>
###xml 4418 4424 4418 4424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gprin1</italic>
###xml 4418 4424 4418 4424 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>Gprin1</italic></td>
###xml 4424 4441 4424 4441 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Neurite formation</td>
###xml 4442 4444 4442 4444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 4441 4445 4441 4445 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td>
###xml 4418 4445 4418 4445 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>Gprin1</italic></td><td rowspan="1" colspan="1">Neurite formation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr>
###xml 4445 4450 4445 4450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 4445 4450 4445 4450 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>Mef2c</italic></td>
###xml 4450 4460 4450 4460 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Myogenesis</td>
###xml 4461 4463 4461 4463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 4460 4464 4460 4464 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td>
###xml 4445 4464 4445 4464 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>Mef2c</italic></td><td rowspan="1" colspan="1">Myogenesis</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr>
###xml 4464 4469 4464 4469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2bp1</italic>
###xml 4464 4469 4464 4469 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>A2bp1</italic></td>
###xml 4469 4477 4469 4477 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Splicing</td>
###xml 4478 4480 4478 4480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 4477 4481 4477 4481 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td>
###xml 4464 4481 4464 4481 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>A2bp1</italic></td><td rowspan="1" colspan="1">Splicing</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr>
###xml 4481 4486 4481 4486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Creb1</italic>
###xml 4481 4486 4481 4486 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>Creb1</italic></td>
###xml 4486 4514 4486 4514 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Transcriptional co-activator</td>
###xml 4515 4517 4515 4517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 4514 4518 4514 4518 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td>
###xml 4481 4518 4481 4518 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>Creb1</italic></td><td rowspan="1" colspan="1">Transcriptional co-activator</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr>
###xml 3677 4518 3677 4518 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1"><italic>xHairy2a</italic></td><td rowspan="1" colspan="1">Neuronal repressor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B56">56</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>BDNF/Bdnf</italic></td><td rowspan="1" colspan="1">Long term potentiation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B81">81</xref>,<xref ref-type="bibr" rid="B90">90</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>IGF2</italic></td><td rowspan="1" colspan="1">Cell proliferation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B91">91</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>MPP1</italic></td><td rowspan="1" colspan="1">Signal transduction</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B91">91</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>UBE3A/Ube3a</italic></td><td rowspan="1" colspan="1">Proteolysis</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B92">92</xref>,<xref ref-type="bibr" rid="B93">93</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>GABRB3/Gabrb3</italic></td><td rowspan="1" colspan="1">GABA receptor subunit</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B92">92</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>DLX5/Dlx5</italic></td><td rowspan="1" colspan="1">Transcription factor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Dlx6</italic></td><td rowspan="1" colspan="1">Transcription factor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Fkbp5</italic></td><td rowspan="1" colspan="1">Hormone signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B94">94</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Sgk1</italic></td><td rowspan="1" colspan="1">Ion channel activation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B94">94</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>ID1/Id1, ID2/Id2, ID3/Id3</italic></td><td rowspan="1" colspan="1">Transcriptional regulation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B95">95</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Uqcrc1</italic></td><td rowspan="1" colspan="1">Mitochondrial respiratory complex subunit</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B59">59</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Crh</italic></td><td rowspan="1" colspan="1">Anxiety and stress response</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B96">96</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>IGFBP3/Igfbp3</italic></td><td rowspan="1" colspan="1">Hormone signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B97">97</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>FXYD1/Fxyd1</italic></td><td rowspan="1" colspan="1">Na<sup>+</sup>/K<sup>+</sup>-ATPase activity</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B99">99</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Reln</italic></td><td rowspan="1" colspan="1">Cell signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B99">99</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Gtl2/Meg3</italic></td><td rowspan="1" colspan="1">Non-coding RNA</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B99">99</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>JUNB</italic></td><td rowspan="1" colspan="1">Early response gene, Oncogene</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B42">42</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>RNASEH2A</italic></td><td rowspan="1" colspan="1">Ribonucleotide cleavage from RNA&#8211;DNA complex</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B42">42</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Sst</italic></td><td rowspan="1" colspan="1">Hormone signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Oprk1</italic></td><td rowspan="1" colspan="1">Opioid receptor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Gamt</italic></td><td rowspan="1" colspan="1">Methyltransferase</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Gprin1</italic></td><td rowspan="1" colspan="1">Neurite formation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Mef2c</italic></td><td rowspan="1" colspan="1">Myogenesis</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>A2bp1</italic></td><td rowspan="1" colspan="1">Splicing</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Creb1</italic></td><td rowspan="1" colspan="1">Transcriptional co-activator</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr></tbody>
###xml 3655 4518 3655 4518 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Function</th><th rowspan="1" colspan="1">References</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1"><italic>xHairy2a</italic></td><td rowspan="1" colspan="1">Neuronal repressor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B56">56</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>BDNF/Bdnf</italic></td><td rowspan="1" colspan="1">Long term potentiation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B81">81</xref>,<xref ref-type="bibr" rid="B90">90</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>IGF2</italic></td><td rowspan="1" colspan="1">Cell proliferation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B91">91</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>MPP1</italic></td><td rowspan="1" colspan="1">Signal transduction</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B91">91</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>UBE3A/Ube3a</italic></td><td rowspan="1" colspan="1">Proteolysis</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B92">92</xref>,<xref ref-type="bibr" rid="B93">93</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>GABRB3/Gabrb3</italic></td><td rowspan="1" colspan="1">GABA receptor subunit</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B92">92</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>DLX5/Dlx5</italic></td><td rowspan="1" colspan="1">Transcription factor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Dlx6</italic></td><td rowspan="1" colspan="1">Transcription factor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Fkbp5</italic></td><td rowspan="1" colspan="1">Hormone signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B94">94</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Sgk1</italic></td><td rowspan="1" colspan="1">Ion channel activation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B94">94</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>ID1/Id1, ID2/Id2, ID3/Id3</italic></td><td rowspan="1" colspan="1">Transcriptional regulation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B95">95</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Uqcrc1</italic></td><td rowspan="1" colspan="1">Mitochondrial respiratory complex subunit</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B59">59</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Crh</italic></td><td rowspan="1" colspan="1">Anxiety and stress response</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B96">96</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>IGFBP3/Igfbp3</italic></td><td rowspan="1" colspan="1">Hormone signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B97">97</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>FXYD1/Fxyd1</italic></td><td rowspan="1" colspan="1">Na<sup>+</sup>/K<sup>+</sup>-ATPase activity</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B99">99</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Reln</italic></td><td rowspan="1" colspan="1">Cell signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B99">99</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Gtl2/Meg3</italic></td><td rowspan="1" colspan="1">Non-coding RNA</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B99">99</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>JUNB</italic></td><td rowspan="1" colspan="1">Early response gene, Oncogene</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B42">42</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>RNASEH2A</italic></td><td rowspan="1" colspan="1">Ribonucleotide cleavage from RNA&#8211;DNA complex</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B42">42</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Sst</italic></td><td rowspan="1" colspan="1">Hormone signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Oprk1</italic></td><td rowspan="1" colspan="1">Opioid receptor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Gamt</italic></td><td rowspan="1" colspan="1">Methyltransferase</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Gprin1</italic></td><td rowspan="1" colspan="1">Neurite formation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Mef2c</italic></td><td rowspan="1" colspan="1">Myogenesis</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>A2bp1</italic></td><td rowspan="1" colspan="1">Splicing</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Creb1</italic></td><td rowspan="1" colspan="1">Transcriptional co-activator</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr></tbody></table>
###xml 4764 4768 4764 4768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLX5</italic>
###xml 4769 4773 4769 4773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlx5</italic>
###xml 4778 4782 4778 4782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlx6</italic>
###xml 4784 4786 4784 4786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 4792 4797 4792 4797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ube3a</italic>
###xml 4799 4802 4799 4802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B100">100</xref>
###xml 4890 4895 4890 4895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBE3A</italic>
###xml 4896 4901 4896 4901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ube3a</italic>
###xml 4903 4905 4903 4905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B92">92</xref>
###xml 4906 4908 4906 4908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B93">93</xref>
###xml 4914 4919 4914 4919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FXYD1</italic>
###xml 4920 4925 4920 4925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fxyd1</italic>
###xml 4927 4929 4927 4929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B98">98</xref>
###xml 4930 4932 4930 4932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B99">99</xref>
###xml 4952 4955 4952 4955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sst</italic>
###xml 4957 4962 4957 4962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oprk1</italic>
###xml 4964 4968 4964 4968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gamt</italic>
###xml 4970 4976 4970 4976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gprin1</italic>
###xml 4981 4986 4981 4986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Creb1</italic>
###xml 5026 5028 5026 5028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 4518 5030 4518 5030 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="17">The table includes genes shown to bind MeCP2/xMeCP2 directly and with expression that is altered in the presence of dysfunctional MeCP2/xMeCP2. It should be noted, however, that independent studies have not confirmed MeCP2-mediated regulation of <italic>DLX5</italic>/<italic>Dlx5</italic> and <italic>Dlx6</italic> (<xref ref-type="bibr" rid="B41">41</xref>) and <italic>Ube3a</italic> (<xref ref-type="bibr" rid="B100">100</xref>). Furthermore, there are some inconsistencies in the results of the groups identifying <italic>UBE3A</italic>/<italic>Ube3a</italic> (<xref ref-type="bibr" rid="B92">92</xref>,<xref ref-type="bibr" rid="B93">93</xref>) and <italic>FXYD1</italic>/<italic>Fxyd1</italic> (<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B99">99</xref>) as MeCP2 targets. <italic>Sst</italic>, <italic>Oprk1</italic>, <italic>Gamt</italic>, <italic>Gprin1</italic> and <italic>Creb1</italic> are reported to be activated by MeCP2 (<xref ref-type="bibr" rid="B43">43</xref>).</p>
###xml 4518 5030 4518 5030 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="17">The table includes genes shown to bind MeCP2/xMeCP2 directly and with expression that is altered in the presence of dysfunctional MeCP2/xMeCP2. It should be noted, however, that independent studies have not confirmed MeCP2-mediated regulation of <italic>DLX5</italic>/<italic>Dlx5</italic> and <italic>Dlx6</italic> (<xref ref-type="bibr" rid="B41">41</xref>) and <italic>Ube3a</italic> (<xref ref-type="bibr" rid="B100">100</xref>). Furthermore, there are some inconsistencies in the results of the groups identifying <italic>UBE3A</italic>/<italic>Ube3a</italic> (<xref ref-type="bibr" rid="B92">92</xref>,<xref ref-type="bibr" rid="B93">93</xref>) and <italic>FXYD1</italic>/<italic>Fxyd1</italic> (<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B99">99</xref>) as MeCP2 targets. <italic>Sst</italic>, <italic>Oprk1</italic>, <italic>Gamt</italic>, <italic>Gprin1</italic> and <italic>Creb1</italic> are reported to be activated by MeCP2 (<xref ref-type="bibr" rid="B43">43</xref>).</p></fn>
###xml 4518 5030 4518 5030 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn><p textid="17">The table includes genes shown to bind MeCP2/xMeCP2 directly and with expression that is altered in the presence of dysfunctional MeCP2/xMeCP2. It should be noted, however, that independent studies have not confirmed MeCP2-mediated regulation of <italic>DLX5</italic>/<italic>Dlx5</italic> and <italic>Dlx6</italic> (<xref ref-type="bibr" rid="B41">41</xref>) and <italic>Ube3a</italic> (<xref ref-type="bibr" rid="B100">100</xref>). Furthermore, there are some inconsistencies in the results of the groups identifying <italic>UBE3A</italic>/<italic>Ube3a</italic> (<xref ref-type="bibr" rid="B92">92</xref>,<xref ref-type="bibr" rid="B93">93</xref>) and <italic>FXYD1</italic>/<italic>Fxyd1</italic> (<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B99">99</xref>) as MeCP2 targets. <italic>Sst</italic>, <italic>Oprk1</italic>, <italic>Gamt</italic>, <italic>Gprin1</italic> and <italic>Creb1</italic> are reported to be activated by MeCP2 (<xref ref-type="bibr" rid="B43">43</xref>).</p></fn></table-wrap-foot>
###xml 3629 5030 3629 5030 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1.</label><caption><p textid="16">MeCP2 target genes</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Function</th><th rowspan="1" colspan="1">References</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1"><italic>xHairy2a</italic></td><td rowspan="1" colspan="1">Neuronal repressor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B56">56</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>BDNF/Bdnf</italic></td><td rowspan="1" colspan="1">Long term potentiation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B81">81</xref>,<xref ref-type="bibr" rid="B90">90</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>IGF2</italic></td><td rowspan="1" colspan="1">Cell proliferation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B91">91</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>MPP1</italic></td><td rowspan="1" colspan="1">Signal transduction</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B91">91</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>UBE3A/Ube3a</italic></td><td rowspan="1" colspan="1">Proteolysis</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B92">92</xref>,<xref ref-type="bibr" rid="B93">93</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>GABRB3/Gabrb3</italic></td><td rowspan="1" colspan="1">GABA receptor subunit</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B92">92</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>DLX5/Dlx5</italic></td><td rowspan="1" colspan="1">Transcription factor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Dlx6</italic></td><td rowspan="1" colspan="1">Transcription factor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Fkbp5</italic></td><td rowspan="1" colspan="1">Hormone signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B94">94</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Sgk1</italic></td><td rowspan="1" colspan="1">Ion channel activation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B94">94</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>ID1/Id1, ID2/Id2, ID3/Id3</italic></td><td rowspan="1" colspan="1">Transcriptional regulation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B95">95</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Uqcrc1</italic></td><td rowspan="1" colspan="1">Mitochondrial respiratory complex subunit</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B59">59</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Crh</italic></td><td rowspan="1" colspan="1">Anxiety and stress response</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B96">96</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>IGFBP3/Igfbp3</italic></td><td rowspan="1" colspan="1">Hormone signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B97">97</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>FXYD1/Fxyd1</italic></td><td rowspan="1" colspan="1">Na<sup>+</sup>/K<sup>+</sup>-ATPase activity</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B99">99</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Reln</italic></td><td rowspan="1" colspan="1">Cell signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B99">99</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Gtl2/Meg3</italic></td><td rowspan="1" colspan="1">Non-coding RNA</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B99">99</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>JUNB</italic></td><td rowspan="1" colspan="1">Early response gene, Oncogene</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B42">42</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>RNASEH2A</italic></td><td rowspan="1" colspan="1">Ribonucleotide cleavage from RNA&#8211;DNA complex</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B42">42</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Sst</italic></td><td rowspan="1" colspan="1">Hormone signalling</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Oprk1</italic></td><td rowspan="1" colspan="1">Opioid receptor</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Gamt</italic></td><td rowspan="1" colspan="1">Methyltransferase</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Gprin1</italic></td><td rowspan="1" colspan="1">Neurite formation</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Mef2c</italic></td><td rowspan="1" colspan="1">Myogenesis</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>A2bp1</italic></td><td rowspan="1" colspan="1">Splicing</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>Creb1</italic></td><td rowspan="1" colspan="1">Transcriptional co-activator</td><td rowspan="1" colspan="1">(<xref ref-type="bibr" rid="B43">43</xref>)</td></tr></tbody></table><table-wrap-foot><fn><p textid="17">The table includes genes shown to bind MeCP2/xMeCP2 directly and with expression that is altered in the presence of dysfunctional MeCP2/xMeCP2. It should be noted, however, that independent studies have not confirmed MeCP2-mediated regulation of <italic>DLX5</italic>/<italic>Dlx5</italic> and <italic>Dlx6</italic> (<xref ref-type="bibr" rid="B41">41</xref>) and <italic>Ube3a</italic> (<xref ref-type="bibr" rid="B100">100</xref>). Furthermore, there are some inconsistencies in the results of the groups identifying <italic>UBE3A</italic>/<italic>Ube3a</italic> (<xref ref-type="bibr" rid="B92">92</xref>,<xref ref-type="bibr" rid="B93">93</xref>) and <italic>FXYD1</italic>/<italic>Fxyd1</italic> (<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B99">99</xref>) as MeCP2 targets. <italic>Sst</italic>, <italic>Oprk1</italic>, <italic>Gamt</italic>, <italic>Gprin1</italic> and <italic>Creb1</italic> are reported to be activated by MeCP2 (<xref ref-type="bibr" rid="B43">43</xref>).</p></fn></table-wrap-foot></table-wrap>
###xml 2896 2900 <span type="species:ncbi:10090">mice</span>
###xml 3402 3406 <span type="species:ncbi:10090">mice</span>
MeCP2 was first identified as a protein capable of binding to methylated DNA (18), although it was soon noted to have a weaker affinity for unmethylated DNA as well (19,20). MeCP2 differs from its other methyl-DNA-binding family members (21,22), by its specific and high-affinity binding to symmetrically methylated CpG dinucleotides (18). More recently, it has been recognized that MeCP2 requires an A/T run of four or more bases adjacent to the methyl-CpG for efficient DNA binding (23). As DNA methylation was known to be an important mechanism for regulating gene expression (24) and MeCP2 had been shown to localize to heterochromatin (18,25), it seemed likely, and was soon confirmed, that MeCP2 could function as a transcriptional repressor (26). Although initially described as a global transcriptional repressor, a limited number of targets of MeCP2-mediated regulation have now been identified (Table 1). The most well-established mechanism by which MeCP2 is able to repress transcription involves the recruitment of co-repressor complexes containing histone deacetylases that are able to alter chromatin structure (27-29). However, as trichostatin A, a histone deacetylase inhibitor, does not entirely relieve the transcriptional repression conferred by MeCP2 (27,28), it is evident that MeCP2 must also be able to regulate transcription independently of HDACs, and several such HDAC-independent mechanisms have been proposed. Kaludov and Wolffe (30) demonstrated that MeCP2 is still able to repress transcription in vitro in the absence of histones by interacting with transcription factor IIB (TFIIB) to prevent assembly of the pre-initiation complex. MeCP2 may also interact with other chromatin-modifying enzymes or complexes, including histone methyltransferase (31), Brm and SWI/SNF (32) and ATRX (33). MeCP2 may also be able to directly influence chromatin structure. MeCP2 binds to methylated linker DNA in nucleosome arrays (34) and induces chromatin compaction in vitro by mediating nucleosome-nucleosome interactions. Interestingly, MeCP2 also mediates conformational changes in naked DNA in vitro, including cross-linking of two or more DNA molecules (35-37). Consistent with its role as a chromatin-binding protein, MeCP2 was shown to be capable of binding to four-way DNA junctions, a property that is shared by several other proteins including HP1, HMGB1 and the SWI/SNF complex (38). The interaction of MeCP2 with chromatin is transient and dynamic, as demonstrated by rapid recovery of fluorescence after photobleaching (39). It is also proposed that MeCP2 may be involved in the formation of a chromatin loop at the Dlx5 and Dlx6 genes that results in silencing of these genes. Horike et al. (40) identified a MeCP2-binding site near Dlx5 and Dlx6, and observed that transcript levels from each of these genes were elevated 2-fold in the frontal cortex of Mecp2-null mice when compared to wild type. They went on to perform chromatin conformation capture (3C) assays and concluded that normal silencing of Dlx5 and Dlx6 was the result of a chromatin loop that was not detected in Mecp2-null cells, suggesting that MeCP2 mediated formation of this loop. While MeCP2 may be able to form such structures, at least in vitro, Schule et al. (41) have been unable to detect a reproducible or significant increase in expression of Dlx5 and Dlx6 in the frontal cortex of Mecp2-null mice. As a result, the role of MeCP2 in the silencing of these genes is now in doubt, although MeCP2-binding sites within the DLX5/DLX6 locus have been confirmed by independent chromatin-immunoprecipitation (ChIP) assays (42). Table 1.MeCP2 target genesGeneFunctionReferencesxHairy2aNeuronal repressor(56)BDNF/BdnfLong term potentiation(81,90)IGF2Cell proliferation(91)MPP1Signal transduction(91)UBE3A/Ube3aProteolysis(92,93)GABRB3/Gabrb3GABA receptor subunit(92)DLX5/Dlx5Transcription factor(40)Dlx6Transcription factor(23,40)Fkbp5Hormone signalling(94)Sgk1Ion channel activation(94)ID1/Id1, ID2/Id2, ID3/Id3Transcriptional regulation(95)Uqcrc1Mitochondrial respiratory complex subunit(59)CrhAnxiety and stress response(96)IGFBP3/Igfbp3Hormone signalling(97)FXYD1/Fxyd1Na+/K+-ATPase activity(98,99)RelnCell signalling(99)Gtl2/Meg3Non-coding RNA(99)JUNBEarly response gene, Oncogene(42)RNASEH2ARibonucleotide cleavage from RNA-DNA complex(42)SstHormone signalling(43)Oprk1Opioid receptor(43)GamtMethyltransferase(43)Gprin1Neurite formation(43)Mef2cMyogenesis(43)A2bp1Splicing(43)Creb1Transcriptional co-activator(43)The table includes genes shown to bind MeCP2/xMeCP2 directly and with expression that is altered in the presence of dysfunctional MeCP2/xMeCP2. It should be noted, however, that independent studies have not confirmed MeCP2-mediated regulation of DLX5/Dlx5 and Dlx6 (41) and Ube3a (100). Furthermore, there are some inconsistencies in the results of the groups identifying UBE3A/Ube3a (92,93) and FXYD1/Fxyd1 (98,99) as MeCP2 targets. Sst, Oprk1, Gamt, Gprin1 and Creb1 are reported to be activated by MeCP2 (43).
###end p 15
###begin p 16
MeCP2 target genes
###end p 16
###begin p 17
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLX5</italic>
###xml 251 255 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlx5</italic>
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlx6</italic>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ube3a</italic>
###xml 281 284 281 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B100">100</xref>
###xml 372 377 372 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBE3A</italic>
###xml 378 383 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ube3a</italic>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B92">92</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B93">93</xref>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FXYD1</italic>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fxyd1</italic>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B98">98</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B99">99</xref>
###xml 434 437 434 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sst</italic>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oprk1</italic>
###xml 446 450 446 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gamt</italic>
###xml 452 458 452 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gprin1</italic>
###xml 463 468 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Creb1</italic>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
The table includes genes shown to bind MeCP2/xMeCP2 directly and with expression that is altered in the presence of dysfunctional MeCP2/xMeCP2. It should be noted, however, that independent studies have not confirmed MeCP2-mediated regulation of DLX5/Dlx5 and Dlx6 (41) and Ube3a (100). Furthermore, there are some inconsistencies in the results of the groups identifying UBE3A/Ube3a (92,93) and FXYD1/Fxyd1 (98,99) as MeCP2 targets. Sst, Oprk1, Gamt, Gprin1 and Creb1 are reported to be activated by MeCP2 (43).
###end p 17
###begin p 18
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 846 850 846 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JUNB</italic>
###xml 852 854 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 881 887 881 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 1082 1087 1082 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1128 1133 1128 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1271 1277 1271 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1279 1281 1279 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 1519 1522 1519 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sst</italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 1093 1097 <span type="species:ncbi:10090">mice</span>
###xml 1149 1153 <span type="species:ncbi:10090">mice</span>
A recent study of MeCP2-binding sites within a human neuronal cell line has also provided evidence that MeCP2 function extends beyond transcriptional repression mediated by binding to methylated promoters (42). In this analysis, ChIP assays revealed that CpG islands and transcriptionally silent promoters constitute only a minority of MeCP2-binding sites. Instead, a large number of MeCP2-binding sites are intergenic, consistent with a role for MeCP2 in long-range chromatin modifications. Another interesting observation from this analysis was a correlation between MeCP2 and RNA polymerase II binding sites, which suggests that MeCP2 often binds to transcriptionally active promoters. In this setting, MeCP2 may be functioning to downregulate rather than completely silence gene expression from these promoters, as appears to be the case for JUNB (42). Alternatively, Chahrour et al. (43) have recently proposed that MeCP2 can function as a transcriptional activator. This hypothesis arose from observations that a large number of genes were downregulated in the hypothalami of Mecp2-null mice but upregulated in transgenic Mecp2-overexpressing mice relative to wild-type controls, a result that contradicts the idea of MeCP2 as a transcriptional repressor. Chahrour et al. (43) went on to confirm binding of MeCP2 to the promoter regions of four of these activated genes. Furthermore, they showed that MeCP2 co-immunoprecipitates the co-activator CREB-1 and that both MeCP2 and CREB-1 binding were enriched at the Sst promoter, one of the presumed targets of MeCP2-mediated activation. Thus, it appears that MeCP2 may be more correctly referred to as a transcriptional modulator than a transcriptional repressor. If MeCP2 is indeed able to activate as well as repress transcription, it will be interesting to identify which regions of the MeCP2 protein are involved in the recruitment of transcriptional co-activators and how MeCP2 is able to specifically recruit co-repressors in some instances and co-activators in others.
###end p 18
###begin p 19
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 327 335 327 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 632 641 632 641 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 641 646 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 726 731 726 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1288 1290 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 641 1311 641 1311 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="20"><italic>MECP2</italic> coding regions and functional protein domains. The four annotated exons of the <italic>MECP2</italic> gene are magnified and their coding portions are shown in colour, with the non-coding portions represented in grey. The MeCP2_e1 and MeCP2_e2 isoforms are also displayed. The 3&#8242;-UTR, with four alternative polyadenylation signals, and the 5&#8242;-UTR of each transcript are also shown. The positions of the well-characterized MBD, TRD and nuclear localization signals of the MeCP2 protein as well as the more-recently identified WDR and RG repeat region are as labelled. The distinct tertiary structures and functional domains defined by trypsin cleavage sites (<xref ref-type="bibr" rid="B46">46</xref>) are also indicated.</p>
###xml 641 1311 641 1311 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="20"><italic>MECP2</italic> coding regions and functional protein domains. The four annotated exons of the <italic>MECP2</italic> gene are magnified and their coding portions are shown in colour, with the non-coding portions represented in grey. The MeCP2_e1 and MeCP2_e2 isoforms are also displayed. The 3&#8242;-UTR, with four alternative polyadenylation signals, and the 5&#8242;-UTR of each transcript are also shown. The positions of the well-characterized MBD, TRD and nuclear localization signals of the MeCP2 protein as well as the more-recently identified WDR and RG repeat region are as labelled. The distinct tertiary structures and functional domains defined by trypsin cleavage sites (<xref ref-type="bibr" rid="B46">46</xref>) are also indicated.</p></caption>
###xml 1311 1311 1311 1311 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn591f2"/>
###xml 632 1311 632 1311 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="20"><italic>MECP2</italic> coding regions and functional protein domains. The four annotated exons of the <italic>MECP2</italic> gene are magnified and their coding portions are shown in colour, with the non-coding portions represented in grey. The MeCP2_e1 and MeCP2_e2 isoforms are also displayed. The 3&#8242;-UTR, with four alternative polyadenylation signals, and the 5&#8242;-UTR of each transcript are also shown. The positions of the well-characterized MBD, TRD and nuclear localization signals of the MeCP2 protein as well as the more-recently identified WDR and RG repeat region are as labelled. The distinct tertiary structures and functional domains defined by trypsin cleavage sites (<xref ref-type="bibr" rid="B46">46</xref>) are also indicated.</p></caption><graphic xlink:href="gkn591f2"/></fig>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
Beyond a role in transcriptional regulation, MeCP2 has also been implicated in alternative splicing as part of an RNA-protein complex (44,45), and genome-wide alterations in RNA splicing have been observed in mice with MeCP2 dysfunction (45). The recent delineation of at least six biochemically distinct domains within MeCP2 (Figure 2), along with the recognition that MeCP2 has a disordered tertiary structure potentially allowing different combinations of domains to act together for specific functions (46), provide a strengthened framework for understanding the various structural elements within this multifunctional protein. Figure 2.MECP2 coding regions and functional protein domains. The four annotated exons of the MECP2 gene are magnified and their coding portions are shown in colour, with the non-coding portions represented in grey. The MeCP2_e1 and MeCP2_e2 isoforms are also displayed. The 3'-UTR, with four alternative polyadenylation signals, and the 5'-UTR of each transcript are also shown. The positions of the well-characterized MBD, TRD and nuclear localization signals of the MeCP2 protein as well as the more-recently identified WDR and RG repeat region are as labelled. The distinct tertiary structures and functional domains defined by trypsin cleavage sites (46) are also indicated.
###end p 19
###begin p 20
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
MECP2 coding regions and functional protein domains. The four annotated exons of the MECP2 gene are magnified and their coding portions are shown in colour, with the non-coding portions represented in grey. The MeCP2_e1 and MeCP2_e2 isoforms are also displayed. The 3'-UTR, with four alternative polyadenylation signals, and the 5'-UTR of each transcript are also shown. The positions of the well-characterized MBD, TRD and nuclear localization signals of the MeCP2 protein as well as the more-recently identified WDR and RG repeat region are as labelled. The distinct tertiary structures and functional domains defined by trypsin cleavage sites (46) are also indicated.
###end p 20
###begin title 21
MECP2 DYSFUNCTION
###end title 21
###begin p 22
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 628 633 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1082 1084 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 1085 1087 1085 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 342 347 <span type="species:ncbi:9606">girls</span>
###xml 907 915 <span type="species:ncbi:9606">patients</span>
MeCP2 shows complex spatial and temporal patterns of distribution, and both up- and down-regulation of MeCP2 may have disastrous consequences. Mutations in MECP2 resulting in loss-of-function are implicated in several neurological disorders including Rett Syndrome (RTT), which is a severe neurodevelopmental disorder predominantly affecting girls. RTT is characterized typically by a period of seemingly normal development followed by the onset of decelerating developmental milestone achievements and brain growth, loss of purposeful hand movements and language skills, seizures and respiratory dysfunction (47). Mutations in MECP2 are also implicated in a minority of cases presenting clinically as Angelman syndrome, autistic spectrum disorder, non-specific mental retardation and neonatal encephalopathy. Decreased MeCP2 expression, in the absence of coding region mutations, has also been observed in patients with RTT and other neurodevelopmental disorders such as autism, Angelman syndrome, Prader-Willi syndrome, Down syndrome and attention-deficit hyperactivity disorder (48,49).
###end p 22
###begin p 23
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 141 146 141 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 261 266 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 233 239 <span type="species:ncbi:9606">humans</span>
More recently it has been established that an increase in MECP2 dosage is also highly detrimental to normal central nervous system function. Mecp2 over-expression in mice is associated with seizures, hypoactivity and ataxia (50). In humans, duplications of the MECP2 gene are now also recognized among males with a phenotype of severe mental retardation, hypotonia, recurrent respiratory infections, absence of speech development, seizures and spasticity (51).
###end p 23
###begin p 24
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bdnf</italic>
###xml 369 376 369 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bdnf</italic>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 543 550 543 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 569 577 569 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">xHairy2a</italic>
###xml 629 637 629 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">xHairy2a</italic>
###xml 756 764 756 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">xHairy2a</italic>
###xml 846 854 846 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">xHairy2a</italic>
###xml 939 950 939 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch-Delta</italic>
###xml 1018 1026 1018 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">xHairy2a</italic>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 1132 1134 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 1240 1242 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 1243 1245 1243 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 543 550 <span type="species:ncbi:8355">Xenopus</span>
###xml 1071 1075 <span type="species:ncbi:10090">mice</span>
Consistent with the brain-specific phenotype associated with MECP2 dysfunction, MeCP2 is hypothesized to regulate genes involved in neuronal maturation and in maintaining synaptic plasticity. Several neuronal-related genes have been observed to be dysregulated in the brains of Mecp2-mutant mice (43,52,53). Bdnf, which has been identified as a direct target of MeCP2 (Table 1), is particularly interesting given its role in neuronal development and plasticity, as well as the phenotypic overlap between mice lacking Bdnf or Mecp2 (54,55). In Xenopus, xMeCP2 regulates xHairy2a expression and is involved in cell-fate decisions. xHairy2a is one of a family of genes involved in repressing neuronal differentiation, and xMeCP2-null embryos show upregulated xHairy2a and fewer differentiated neurons. It is hypothesized that xMeCP2 may help reduce xHairy2a expression by recruiting the Sin3A-containing SMRT complex, until activation of the Notch-Delta signalling pathway causes SMRT-bound xMeCP2 to dissociate from the xHairy2a promoter region (56). By contrast, MeCP2 in mice does not appear to influence early cell-fate decisions (57), although it does still recruit co-repressors and co-activators to genes relevant to neuronal function (43,55).
###end p 24
###begin title 25
THE MECP2 PROTEIN
###end title 25
###begin p 26
###xml 225 233 225 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 303 309 303 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 654 660 654 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 1339 1345 1339 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1347 1349 1347 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 1477 1484 1477 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2e1</italic>
###xml 1489 1496 1489 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2e2</italic>
###xml 1688 1690 1688 1690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 497 502 <span type="species:ncbi:9606">human</span>
###xml 1471 1476 <span type="species:ncbi:10090">mouse</span>
Two MeCP2 isoforms are recognized, MeCP2_e1 (e1) and MeCP2_e2 (e2). The e1 isoform is 498 amino acids in length and encoded by exons 1, 3 and 4, whereas the e2 isoform is 486 amino acids long and encoded by exons 2, 3 and 4 [Figure 2; refs. (58,59)]. Upon identifying the MeCP2_e1 isoform, Mnatzakanian et al. (58) observed that it may be of greater clinical relevance than the e2 isoform, as it is the sole isoform in non-mammalian vertebrates and its transcript is 10 times more abundant in the human adult brain than that of e2. Furthermore, while no RTT-associated mutations have been characterized within exon 2, which is unique to e2, Mnatzakanian et al. (58) were the first to report pathogenic mutations in exon 1, which encodes the unique N-terminal to e1. It was initially assumed that such exon 1 mutations had no effect on the e2 protein isoform, as e2 transcript levels were observed to be unchanged (58). However, it has since been demonstrated that exon 1 mutations may be associated with a reduction in e2 protein levels despite the presence of e2 transcripts, possibly through translational interference (60). Thus the question remains of whether MeCP2_e2 is truly redundant, or whether it may have some unique function that, when disrupted, contributes to the RTT phenotype. In support of the latter possibility, Dragich et al. (61) have demonstrated that, in addition to the two isoforms having amino termini with unique physiochemical properties, the mouse Mecp2e1 and Mecp2e2 transcripts show distinct expression patterns within different brain regions and developmental stages, and show different preferences for alternative polyadenylation sites within the 3'-UTR (61).
###end p 26
###begin p 27
###xml 215 223 215 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
The domain responsible for specific binding to methylated CpGs (methyl-binding domain or MBD) has been localized to an 85-amino-acid region encoded within exons 3 and 4, which are present in both isoforms of MeCP2 [Figure 2; ref. (20)]. The MBD has been shown to be essential for binding of MeCP2 to heterochromatin (25), as well as to unmethylated four-way DNA junctions (38).
###end p 27
###begin p 28
###xml 331 337 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 770 772 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 945 947 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
The residues on the N-terminal side of the MBD have an amino acid composition very similar to the high mobility group (HMG) proteins, which are examples of proteins in which absence of secondary and tertiary structures permits different combinations of domains to perform different functions. On the basis of this structure, Adams et al. (46) refer to this N-terminal domain as HMGD1. The N-terminal region has recently been shown to interact with the repressive chromatin regulator heterochromatin protein 1 (HP1). This is consistent with observations of simultaneously increased concentrations of MeCP2 and HP1alpha and HP1gamma within heterochromatin during myogenic differentiation, however MeCP2 also binds to HP1beta which does not associate with heterochromatin (62). The N-terminal portion, including HMGD1 and MBD, as well as the C-terminal region have also been shown to have an association with histone H3 methyltransferase activity (31).
###end p 28
###begin p 29
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 1107 1109 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 1205 1213 1205 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
The 104-amino-acid transcription repression domain (TRD) encoded within exon 4 (26) interacts with histone deacetylases (HDACs) and transcriptional co-repressors Sin3A (27,28), c-Ski and N-CoR (29). HDAC1 and HDAC2 are histone deacetylases that combine with transcriptional repressors such as mSin3A to form a co-repressor complex. The TRD also directly interferes with assembly of the pre-initiation complex through interactions with transcription factor IIB (TFIIB), a component of the basal transcriptional machinery (30). The maintenance DNA methyltransferase, Dnmt1, also associates directly with MeCP2 at the TRD, and immunoprecipitated MeCP2-Dnmt1 complexes show DNA methyltransferase activity to hemimethylated DNA, implicating MeCP2 in the maintenance of methylation patterns during DNA replication (63). The TRD, as well as neighbouring sequences, are necessary for the interaction of MeCP2 with Y box binding protein 1 (YB1). YB1, which is an RNA-binding protein, has a number of functions, including a role in alternative splicing and MeCP2, when bound to YB1, influences splice site selection (45). More recently, it has been demonstrated that the TRD is also capable of interacting with DNA in vitro (46).
###end p 29
###begin p 30
###xml 89 97 89 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 213 236 213 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster</italic>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 198 203 <span type="species:ncbi:9606">human</span>
###xml 213 236 <span type="species:ncbi:7227">Drosophila melanogaster</span>
One of two identified nuclear localization signals (NLS) is embedded within the TRD [see Figure 2; ref. (25)]. The other NLS, located in HMGD2, between the MBD and TRD, was identified by expressing human MeCP2 in Drosophila melanogaster cells, and has not been shown to be functional in mammalian cells (64).
###end p 30
###begin p 31
###xml 22 24 22 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 118 126 118 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 417 424 417 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
Jeffery and Nakielny (44) identified an RG (arginine-glycine) repeat region in HMGD2 between amino acids 160 and 200 (Figure 2). RG repeat regions are known to mediate RNA-protein interactions, and MeCP2 was shown to bind to mRNA and double-stranded siRNA independent of its MBD, suggesting that MeCP2 may have activity as part of a selective RNA-protein complex. Further evidence in support of this claim comes from in vivo experiments documenting an RNA-mediated interaction between MeCP2 and YB1 (45).
###end p 31
###begin p 32
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 312 320 312 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 523 531 516 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 539 541 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 620 622 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 688 690 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 865 867 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
###xml 1225 1227 1211 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 1228 1230 1214 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 1330 1337 1316 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1479 1481 1465 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 1113 1118 <span type="species:ncbi:10090">mouse</span>
In vivo, MeCP2 interacts with chromatin via one or more chromatin interaction domains (35,36,38,65). A chromatin-interacting domain is likely to be positioned within the C-terminal, as truncated MeCP2 mutants also show impaired binding to chromatin (36,65) and induce different changes in chromatin architecture in vitro compared to the wild-type MeCP2 (36). The tertiary structural regions predicted by protease digestion mapping suggest that there are two biochemically distinct C-terminal regions, CTDalpha and CTDbeta [Figure 2; ref. (46)]. CTDalpha may contribute to the recognition of methylated DNA in chromatin (36), while CTDbeta encodes the WW-domain-binding region [WDR; ref. (66)]. WW domains are characterized by two tryptophan (W) residues separated by 20-22 amino acids and facilitate protein-protein interactions by recognizing proline-rich motifs (67). WW domains are found in proteins such as the neural Wiskott-Aldrich syndrome protein (N-WASP), and formin-binding protein 11 (FBP11). N-WASP is involved in actin polymerization and cell locomotion, while FBP11 is a splicing-factor involved in mouse limb development and also known to interact with the Huntingtin protein implicated in Huntington disease (66,68). FBP11 has also been shown to interact with MeCP2, and although the precise role of the MeCP2 WDR in vivo remains unclear, mutations reducing WW-binding activity have been identified in cases of RTT as well as mild to moderate mental retardation (66).
###end p 32
###begin title 33
MECP2 EXPRESSION
###end title 33
###begin p 34
###xml 176 181 176 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69 B70 B71">69&#8211;71</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B72">72</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 668 674 668 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B73">73</xref>
###xml 692 697 692 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
###xml 140 145 <span type="species:ncbi:9606">human</span>
###xml 703 708 <span type="species:ncbi:10090">mouse</span>
Expression of MeCP2 is high in the brain, specifically in neurones rather than glia, and increases progressively during mouse embryonic and human post-natal brain development (69-71). Immunohistochemical staining has revealed that the timing of increasing MeCP2 expression is correlated with the pattern of maturation of different brain regions and cell types (69), suggesting that MeCP2 may play a role in neuronal maturation (48,52,69,71,72). Such a function is consistent with well-recognized features of RTT such as apparently normal early development and reduced brain size with decreased dendritic branching (52,69). On the other hand, the recent finding by Guy et al. (73) that in the Mecp2-null mouse, at least, the neurological abnormalities appear to be reversible, strengthens that MeCP2 plays a role in the maintenance of neuronal plasticity. The devastating neurofunctional consequences of inappropriate up- and down-regulation of MeCP2 reveal that a more detailed understanding of the regulatory elements influencing MeCP2 expression could yield more insights into the pathogenic processes prompted by dysregulation of MeCP2 expression.
###end p 34
###begin title 35
REGULATORY ELEMENTS
###end title 35
###begin p 36
###xml 17 19 17 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 382 390 382 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 759 762 759 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 874 883 874 883 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 883 888 883 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 911 912 911 912 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 914 919 914 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 952 955 952 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1007 1009 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 1109 1114 1109 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1128 1130 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B82">82</xref>
###xml 1134 1135 1134 1135 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 1285 1288 1285 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 883 2150 883 2150 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="37"><italic>MECP2</italic> regulatory elements. (<bold>a</bold>) <italic>MECP2</italic> regulatory elements include the <italic>cis</italic>-regulatory elements identified by Liu and Francke (<xref ref-type="bibr" rid="B74">74</xref>) and the TargetScanS-identified binding site for miR-132, which has recently been shown to repress <italic>MECP2</italic> translation (<xref ref-type="bibr" rid="B82">82</xref>). (<bold>b</bold>) A UCSC Genome Browser screenshot (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>, May 2004 assembly) of a 5500-bp region encompassing the promoter and exon 1 is also included. This displays the <italic>cis</italic>-regulatory elements identified in (a) above; CpG islands; repeating elements identified by RepeatMasker; constrained elements defined by ENCODE; single nucleotide polymorphisms (SNPs) from dbSNP build 126 (March 2006 assembly); GENCODE gene annotations (v3.1 March 2007); RIKEN CAGE-predicted transcription start sites (TSSs) on the minus strand; and Yale Regulatory Factor Binding Region (RFBRs) clusters and deserts. DNase I hypersensitivity sites are shown for HeLa (epithelioid carcinoma) and IMR90 (fibroblast) cells, as identified by Duke/NHGRI. The binding of RNA polymerase II (RNA pol II) and TATA-binding protein-associated factor 1 (TAF1); as well as the locations of histone modifications, was determined by ChIP studies performed by Ludwig Institute/UCSD. The Sp1-binding sites were identified by Stanford in K562 (chronic myeloid leukaemia) cells.</p>
###xml 883 2150 883 2150 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="37"><italic>MECP2</italic> regulatory elements. (<bold>a</bold>) <italic>MECP2</italic> regulatory elements include the <italic>cis</italic>-regulatory elements identified by Liu and Francke (<xref ref-type="bibr" rid="B74">74</xref>) and the TargetScanS-identified binding site for miR-132, which has recently been shown to repress <italic>MECP2</italic> translation (<xref ref-type="bibr" rid="B82">82</xref>). (<bold>b</bold>) A UCSC Genome Browser screenshot (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>, May 2004 assembly) of a 5500-bp region encompassing the promoter and exon 1 is also included. This displays the <italic>cis</italic>-regulatory elements identified in (a) above; CpG islands; repeating elements identified by RepeatMasker; constrained elements defined by ENCODE; single nucleotide polymorphisms (SNPs) from dbSNP build 126 (March 2006 assembly); GENCODE gene annotations (v3.1 March 2007); RIKEN CAGE-predicted transcription start sites (TSSs) on the minus strand; and Yale Regulatory Factor Binding Region (RFBRs) clusters and deserts. DNase I hypersensitivity sites are shown for HeLa (epithelioid carcinoma) and IMR90 (fibroblast) cells, as identified by Duke/NHGRI. The binding of RNA polymerase II (RNA pol II) and TATA-binding protein-associated factor 1 (TAF1); as well as the locations of histone modifications, was determined by ChIP studies performed by Ludwig Institute/UCSD. The Sp1-binding sites were identified by Stanford in K562 (chronic myeloid leukaemia) cells.</p></caption>
###xml 2150 2150 2150 2150 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn591f3"/>
###xml 874 2150 874 2150 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="37"><italic>MECP2</italic> regulatory elements. (<bold>a</bold>) <italic>MECP2</italic> regulatory elements include the <italic>cis</italic>-regulatory elements identified by Liu and Francke (<xref ref-type="bibr" rid="B74">74</xref>) and the TargetScanS-identified binding site for miR-132, which has recently been shown to repress <italic>MECP2</italic> translation (<xref ref-type="bibr" rid="B82">82</xref>). (<bold>b</bold>) A UCSC Genome Browser screenshot (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>, May 2004 assembly) of a 5500-bp region encompassing the promoter and exon 1 is also included. This displays the <italic>cis</italic>-regulatory elements identified in (a) above; CpG islands; repeating elements identified by RepeatMasker; constrained elements defined by ENCODE; single nucleotide polymorphisms (SNPs) from dbSNP build 126 (March 2006 assembly); GENCODE gene annotations (v3.1 March 2007); RIKEN CAGE-predicted transcription start sites (TSSs) on the minus strand; and Yale Regulatory Factor Binding Region (RFBRs) clusters and deserts. DNase I hypersensitivity sites are shown for HeLa (epithelioid carcinoma) and IMR90 (fibroblast) cells, as identified by Duke/NHGRI. The binding of RNA polymerase II (RNA pol II) and TATA-binding protein-associated factor 1 (TAF1); as well as the locations of histone modifications, was determined by ChIP studies performed by Ludwig Institute/UCSD. The Sp1-binding sites were identified by Stanford in K562 (chronic myeloid leukaemia) cells.</p></caption><graphic xlink:href="gkn591f3"/></fig>
Liu and Francke (74) recently examined conserved elements throughout the MECP2 gene and its neighbouring regions for regulatory activity, and identified four enhancer and two silencer elements, as well as a conserved fragment spanning 1080 nt immediately upstream of exon 1, which incorporates the MECP2 core promoter and at least one positive and two negative regulatory elements (Figure 3). The identified regulatory elements show cell-specific activity differences. All four enhancers and two silencers were able to interact with nuclear proteins in gel-shift assays, and the enhancer elements contain predicted binding sites for brain-specific transcription factors. Furthermore, three of the enhancers and both of the silencers were shown to interact in cis with the core promoter, providing further support for their potential role in transcriptional regulation (74). Figure 3.MECP2 regulatory elements. (a) MECP2 regulatory elements include the cis-regulatory elements identified by Liu and Francke (74) and the TargetScanS-identified binding site for miR-132, which has recently been shown to repress MECP2 translation (82). (b) A UCSC Genome Browser screenshot (, May 2004 assembly) of a 5500-bp region encompassing the promoter and exon 1 is also included. This displays the cis-regulatory elements identified in (a) above; CpG islands; repeating elements identified by RepeatMasker; constrained elements defined by ENCODE; single nucleotide polymorphisms (SNPs) from dbSNP build 126 (March 2006 assembly); GENCODE gene annotations (v3.1 March 2007); RIKEN CAGE-predicted transcription start sites (TSSs) on the minus strand; and Yale Regulatory Factor Binding Region (RFBRs) clusters and deserts. DNase I hypersensitivity sites are shown for HeLa (epithelioid carcinoma) and IMR90 (fibroblast) cells, as identified by Duke/NHGRI. The binding of RNA polymerase II (RNA pol II) and TATA-binding protein-associated factor 1 (TAF1); as well as the locations of histone modifications, was determined by ChIP studies performed by Ludwig Institute/UCSD. The Sp1-binding sites were identified by Stanford in K562 (chronic myeloid leukaemia) cells.
###end p 36
###begin p 37
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 28 29 28 29 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B82">82</xref>
###xml 251 252 251 252 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 402 405 402 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
MECP2 regulatory elements. (a) MECP2 regulatory elements include the cis-regulatory elements identified by Liu and Francke (74) and the TargetScanS-identified binding site for miR-132, which has recently been shown to repress MECP2 translation (82). (b) A UCSC Genome Browser screenshot (, May 2004 assembly) of a 5500-bp region encompassing the promoter and exon 1 is also included. This displays the cis-regulatory elements identified in (a) above; CpG islands; repeating elements identified by RepeatMasker; constrained elements defined by ENCODE; single nucleotide polymorphisms (SNPs) from dbSNP build 126 (March 2006 assembly); GENCODE gene annotations (v3.1 March 2007); RIKEN CAGE-predicted transcription start sites (TSSs) on the minus strand; and Yale Regulatory Factor Binding Region (RFBRs) clusters and deserts. DNase I hypersensitivity sites are shown for HeLa (epithelioid carcinoma) and IMR90 (fibroblast) cells, as identified by Duke/NHGRI. The binding of RNA polymerase II (RNA pol II) and TATA-binding protein-associated factor 1 (TAF1); as well as the locations of histone modifications, was determined by ChIP studies performed by Ludwig Institute/UCSD. The Sp1-binding sites were identified by Stanford in K562 (chronic myeloid leukaemia) cells.
###end p 37
###begin title 38
Promoter and 5'-UTR
###end title 38
###begin p 39
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B75">75</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B76">76</xref>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 281 289 281 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 954 955 954 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B77">77</xref>
###xml 1089 1094 1089 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1441 1443 1441 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 1493 1501 1493 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1771 1776 1771 1776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1835 1837 1835 1837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
Contrary to the classical description of 'TATA-dependent' core promoters, most core promoters are now believed to be characterized by a high GC content and multiple transcription start sites (TSSs) clustered together over a stretch of 50-100 nt (2,75,76). The MECP2 core promoter (Figure 3), as identified by Liu and Francke (74), is embedded within a CpG island (12), and a region rich with regulatory factor binding sites (). Methylation levels within the promoter region have been shown to correlate inversely with MeCP2 expression, and significantly increased methylation has been observed in male autism cases relative to controls (49). Cap analysis gene expression (CAGE) has revealed a cluster of predicted TSSs upstream of the coding region of exon 1, as well as several Sp1 binding sites. TSSs or TSS clusters, when considered collectively, show distinct patterns of histone modifications, chromatin accessibility and regulatory factor binding (2,77). Consistent with these results, ChIP data from the Ludwig Institute demonstrates that the regions upstream and downstream of the MECP2 TSS cluster are enriched for RNA polymerase II, TAF1 and the activating histone modifications histone 3 lysine 4 dimethylation (H3K4me2) and histone 3 lysine 4 trimethylation (H3K4me3). Histone 3 acetylation (H3ac) is also seen downstream of the TSSs. Furthermore, these ChIP results confirm that the core promoter identified by Liu and Francke (74) binds RNA polymerase II and TAF1 in HeLa cells (Figure 3), as expected for a site upon which the transcription initiation complex is assembled. Polymorphisms in gene promoters can disrupt sequence-specific interactions with regulatory molecules, resulting in altered gene expression. A presumably rare polymorphism within the MECP2 promoter region has been reported in one autistic female (49), and several other polymorphisms, including two within the core promoter, have also been documented ().
###end p 39
###begin title 40
3'-UTR
###end title 40
###begin p 41
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B78">78</xref>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 411 419 411 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 651 659 651 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 799 801 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 802 804 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 805 807 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 808 810 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 826 831 778 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1060 1062 1012 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B80">80</xref>
###xml 1158 1160 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1161 1163 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1238 1240 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1368 1370 1320 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B80">80</xref>
###xml 1373 1382 1325 1334 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1402 1407 1354 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1512 1517 1464 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1876 1884 1828 1836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1382 2357 1334 2309 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="42">Features within the <italic>MECP2</italic> genomic region and adjacent genes. A UCSC Genome Browser screenshot of a 160 000-nt region encompassing <italic>MECP2</italic> and its immediate neighbouring genes (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>, May 2004 assembly) is displayed. The tracks displaying regulatory elements, CpG islands, repetitive elements, constrained elements, SNPs, GENCODE-annotated genes, TSSs, RFBR clusters and deserts, DNase I hypersensitivity, regulatory potential; RNA pol II, TAF1, Sp1 and the histone modifications are all as defined in <xref ref-type="fig" rid="F3">Figure 3</xref>. Also shown are TargetScanS-predicted miRNA-binding sites (March 2006 assembly) deletion-insertion polymorphisms (DIPs) defined by NHGRI, regulatory potential as predicted by ESPERR, CCCTC-binding factor (CTCF) binding sites identified by Sanger in GM06990 (lymphoblastoid) cells and binding sites for CCAAT/enhancer binding protein epsilon (CEBPe), CTCF, P300, PU1 and retinoic acid receptor, alpha (RARA) identified by Affymetrix in HL60 (promyelocytic leukaemia) cells.</p>
###xml 1382 2357 1334 2309 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="42">Features within the <italic>MECP2</italic> genomic region and adjacent genes. A UCSC Genome Browser screenshot of a 160 000-nt region encompassing <italic>MECP2</italic> and its immediate neighbouring genes (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>, May 2004 assembly) is displayed. The tracks displaying regulatory elements, CpG islands, repetitive elements, constrained elements, SNPs, GENCODE-annotated genes, TSSs, RFBR clusters and deserts, DNase I hypersensitivity, regulatory potential; RNA pol II, TAF1, Sp1 and the histone modifications are all as defined in <xref ref-type="fig" rid="F3">Figure 3</xref>. Also shown are TargetScanS-predicted miRNA-binding sites (March 2006 assembly) deletion-insertion polymorphisms (DIPs) defined by NHGRI, regulatory potential as predicted by ESPERR, CCCTC-binding factor (CTCF) binding sites identified by Sanger in GM06990 (lymphoblastoid) cells and binding sites for CCAAT/enhancer binding protein epsilon (CEBPe), CTCF, P300, PU1 and retinoic acid receptor, alpha (RARA) identified by Affymetrix in HL60 (promyelocytic leukaemia) cells.</p></caption>
###xml 2357 2357 2309 2309 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn591f4"/>
###xml 1373 2357 1325 2309 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="42">Features within the <italic>MECP2</italic> genomic region and adjacent genes. A UCSC Genome Browser screenshot of a 160 000-nt region encompassing <italic>MECP2</italic> and its immediate neighbouring genes (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>, May 2004 assembly) is displayed. The tracks displaying regulatory elements, CpG islands, repetitive elements, constrained elements, SNPs, GENCODE-annotated genes, TSSs, RFBR clusters and deserts, DNase I hypersensitivity, regulatory potential; RNA pol II, TAF1, Sp1 and the histone modifications are all as defined in <xref ref-type="fig" rid="F3">Figure 3</xref>. Also shown are TargetScanS-predicted miRNA-binding sites (March 2006 assembly) deletion-insertion polymorphisms (DIPs) defined by NHGRI, regulatory potential as predicted by ESPERR, CCCTC-binding factor (CTCF) binding sites identified by Sanger in GM06990 (lymphoblastoid) cells and binding sites for CCAAT/enhancer binding protein epsilon (CEBPe), CTCF, P300, PU1 and retinoic acid receptor, alpha (RARA) identified by Affymetrix in HL60 (promyelocytic leukaemia) cells.</p></caption><graphic xlink:href="gkn591f4"/></fig>
###xml 310 315 <span type="species:ncbi:10090">mouse</span>
###xml 320 325 <span type="species:ncbi:9606">human</span>
3'-UTRs of RNA transcripts are known to have a number of cytoplasmic functions including involvement in post-transcriptional regulation, mRNA stability and mRNA localization (78). The 3'-UTR of MECP2 has attracted particular attention because it is one of the longest 3'-UTRs yet documented. Comparison of the mouse and human 3'-UTR genomic sequences reveals a striking pattern of highly conserved regions [see Figure 4; refs. (12,16)], a finding that has been confirmed by the more stringent measures of evolutionary sequence conservation defined by the ENCODE Consortium (79; ). It extends over 8.5 kb and contains multiple polyadenylation signals (Figure 2) associated with alternative transcripts approximately1.8 kb, approximately5.4 kb, approximately7.5 kb and approximately10.2 kb in length (12,14,16,69). The shortest MECP2 transcript (1.8 kb) uses the canonical 5' - AATAAA - 3' polyadenylation signal, which is usually found 10-30 nucleotides upstream of the cleavage site and is bound by cleavage and polyadenylation specificity factor [CPSF; ref. (80)]. The longest transcript (10.2 kb) instead uses the less-efficient sequence 5' - TATAAA - 3' (12,16). Both polyadenylation signal sequences are followed by a GT-rich region (16), which is known to bind cleavage stimulation factor (CstF), involved in the polyadenylation and 3'-end cleavage of pre-mRNAs (80). Figure 4.Features within the MECP2 genomic region and adjacent genes. A UCSC Genome Browser screenshot of a 160 000-nt region encompassing MECP2 and its immediate neighbouring genes (, May 2004 assembly) is displayed. The tracks displaying regulatory elements, CpG islands, repetitive elements, constrained elements, SNPs, GENCODE-annotated genes, TSSs, RFBR clusters and deserts, DNase I hypersensitivity, regulatory potential; RNA pol II, TAF1, Sp1 and the histone modifications are all as defined in Figure 3. Also shown are TargetScanS-predicted miRNA-binding sites (March 2006 assembly) deletion-insertion polymorphisms (DIPs) defined by NHGRI, regulatory potential as predicted by ESPERR, CCCTC-binding factor (CTCF) binding sites identified by Sanger in GM06990 (lymphoblastoid) cells and binding sites for CCAAT/enhancer binding protein epsilon (CEBPe), CTCF, P300, PU1 and retinoic acid receptor, alpha (RARA) identified by Affymetrix in HL60 (promyelocytic leukaemia) cells.
###end p 41
###begin p 42
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 494 502 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
Features within the MECP2 genomic region and adjacent genes. A UCSC Genome Browser screenshot of a 160 000-nt region encompassing MECP2 and its immediate neighbouring genes (, May 2004 assembly) is displayed. The tracks displaying regulatory elements, CpG islands, repetitive elements, constrained elements, SNPs, GENCODE-annotated genes, TSSs, RFBR clusters and deserts, DNase I hypersensitivity, regulatory potential; RNA pol II, TAF1, Sp1 and the histone modifications are all as defined in Figure 3. Also shown are TargetScanS-predicted miRNA-binding sites (March 2006 assembly) deletion-insertion polymorphisms (DIPs) defined by NHGRI, regulatory potential as predicted by ESPERR, CCCTC-binding factor (CTCF) binding sites identified by Sanger in GM06990 (lymphoblastoid) cells and binding sites for CCAAT/enhancer binding protein epsilon (CEBPe), CTCF, P300, PU1 and retinoic acid receptor, alpha (RARA) identified by Affymetrix in HL60 (promyelocytic leukaemia) cells.
###end p 42
###begin p 43
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B81">81</xref>
###xml 641 646 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
###xml 1210 1212 1210 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1213 1215 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
###xml 173 178 <span type="species:ncbi:9606">human</span>
The alternative MECP2 transcripts show quantitative differences in different tissues (12,14,16,17,69) as well as in different stages of mouse embryonic development (16) and human post-natal brain development (48,71). Given the unique expression patterns of each transcript, it is likely that the 3'-UTR and the alternative transcripts have biological significance. The 3'-UTR was hypothesized to play a role in transcript stability, as it contains conserved regions predicted to influence RNA folding (16), as well as an AT-rich sequence (12,16) known to influence mRNA stability (81). However, a significant difference in the half lives of MECP2 long and short transcripts has not been observed (12), and no simple relationship has been found between alternative transcripts and protein levels across a range of tissues (69) or within individual cells (48). Although a quantitative reduction in the 10.2-kb transcript is seen in parallel with increasing MeCP2 during post-natal brain development (71), this inverse relationship between levels of MeCP2 protein and long 3'-UTR usage does not hold at a cellular level, where neurones with abundant MeCP2 protein have increased levels of the 10.2-kb transcript (17,48).
###end p 43
###begin p 44
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 498 503 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 646 652 646 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B82">82</xref>
###xml 738 743 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 756 764 756 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 916 923 916 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
In addition to protein-protein and protein-DNA interactions, gene expression may also be regulated by RNA-protein, RNA-RNA and RNA-DNA interactions. One mechanism by which 3'-UTRs are known to participate in post-transcriptional regulation is through interactions with proteins or microRNAs (miRNAs). miRNAs are small RNA molecules that may be derived from intronic regions, transposons and processed pseudogenes, as well as exons, and are known to suppress translation by binding to mRNA (1). The MECP2 3'-UTR contains 52 TargetScanS-predicted miRNA-binding sites (). Observing that microRNA 132 (miR132) is highly expressed in the brain, Klein et al. (82) have recently proposed that miR132, which interacts with the 3'-UTR of the long MECP2 transcript (Figure 3), may function as a key regulator of MeCP2 expression. miR132 is induced by BDNF and CREB-1, which are both targets of MeCP2-mediated gene regulation (Table 1), suggesting that miR132 may be involved in feedback loops regulating MeCP2 protein levels (82).
###end p 44
###begin title 45
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
Other recently defined features within the MECP2 genomic region
###end title 45
###begin p 46
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK1</italic>
###xml 231 237 231 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPN1LW</italic>
###xml 257 262 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PN1LW</italic>
###xml 364 369 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK1</italic>
###xml 444 449 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 610 615 586 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 626 628 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B83">83</xref>
###xml 711 716 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 718 726 694 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1020 1025 996 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
Until recently, transcripts from the MECP2 gene locus were limited to a 76-kb interval positioned in the 125-kb gap between the neighbouring genes, encoding the interleukin-1 receptor (IRAK1) and a long-wavelength sensitive opsin (OPN1LW). The interval to OPN1LW, which is transcribed from the opposite strand, is 50 kb and the interval to the annotated exon 1 of IRAK1 (Gencode v3.1, March 2007), which is transcribed in the same direction as MECP2, is approximately2 kb. RACE experiments conducted as part of ENCODE have identified a novel 5'exon in testis that is located approximately40-kb upstream of the MECP2 promoter (83), and greatly reduces the size of the intergenic interval at the telomeric end of MECP2 (Figure 4). Interestingly, the region surrounding the newly identified distal exon contains a CpG island, binds RNA polymerase II and TAF1, and is enriched for the histone modifications H3K4me2, H3K4me3 and H3ac, although to a lesser extent than the region surrounding the currently annotated exon 1 of MECP2.
###end p 46
###begin p 47
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B79">79</xref>
###xml 570 571 570 571 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</underline>
###xml 587 588 587 588 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 596 597 596 597 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</underline>
###xml 604 605 604 605 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</underline>
###xml 623 624 623 624 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</underline>
###xml 631 632 631 632 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</underline>
###xml 1034 1035 1034 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B79">79</xref>
ENCODE has also provided a large resource of comparative genomics data that can assist in the identification of additional MECP2 functional elements. 4.9% of the nucleotides in the ENCODE regions were identified as constrained by at least two (out of a possible three) programs when using at least two of three multiple sequence alignments (2,79). DNase I hypersensitivity is a marker of regions likely to regulate transcriptional activation, and the region around the newly identified upstream exon displays DNaseI hypersensitivity. It is also predicted by the ESPERR (Evolutionary and Sequence Pattern Extraction through Reduced Representation) program to be regulatory, but only small segments are conserved across species. This is consistent with the observation across the ENCODE regions that although over 50% of non-coding functional elements overlap constrained elements, the proportion of constrained nucleotides within these elements is <10%. This compares with a constraint of almost 70% among bases within coding regions (2,79). In light of the extensive additional transcription revealed by ENCODE, it is also interesting to note the binding of RNA polymerase II and TAF1 to several intronic regions corresponding to the 5'-termini of non-coding exons.
###end p 47
###begin p 48
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 385 391 385 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B79">79</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B79">79</xref>
###xml 791 794 791 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 1019 1024 1019 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
It is notable that the novel transcribed regions identified within introns of MECP2 also do not have the high evolutionary constraint seen in coding exons, and several of these, as well as a surprisingly large proportion of non-coding functional elements identified throughout other ENCODE regions, do not show evidence of evolutionary constraint in this stringent analysis. Margulies et al. (79) suggest that this discrepancy may be explained by possibilities such as elements performing functions that offer no evolutionary advantage, or not requiring constraint at the primary sequence level. Another alternative, which they suggest, is that these elements may have evolved more recently and so may be conserved across primates but not other mammals (79). By contrast, all but one of the cis-regulatory elements identified by Liu and Francke (74) overlap these stringently defined constrained elements. It should be noted also that a large proportion of constrained sequences and predicted regulatory regions within MECP2 do not overlap any of the functional elements that have been described to date, providing an indication of the extent of the pool of uncharacterized functional elements.
###end p 48
###begin p 49
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B84">84</xref>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 770 775 770 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B85 B86 B87 B88">85&#8211;88</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 877 882 877 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1102 1107 1102 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1224 1229 1224 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1357 1365 1357 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1206 1214 <span type="species:ncbi:9606">patients</span>
###xml 1593 1601 <span type="species:ncbi:9606">patients</span>
Of the novel GENCODE-annotated MECP2 transcripts, only one has an open reading frame annotated in the UCSC genome browser (), making it likely that the others may function as regulatory ncRNAs. Transcription of ncRNAs from the mammalian genome is an increasingly recognized phenomenon (2,84), and ncRNAs are being implicated in diverse cellular processes, including regulation of various levels of gene expression, regulation of localization and function of other molecules and in the targeting of generic enzymes to specific genomic loci (1). Several recently discovered ncRNAs that have not been well-characterized functionally, have been shown to have regulated expression patterns, suggesting that many ncRNAs have important functions that are yet to be determined (85-88). MeCP2 has been reported to interact with RNA (44), and tissue-specific non-coding transcripts from MECP2 or other genes may be able to regulate MeCP2 expression or function in a tissue-specific manner. In view of these insights, it seems possible that mutations disrupting the secondary structures of regulatory ncRNAs from MECP2 may result in disturbed MeCP2 expression and present clinically with a similar phenotype to those patients who have MECP2 coding-region mutations. As MeCP2 is implicated in neurodevelopmental disorders, the novel transcribed region within intron 1 (Figure 1) that has been detected in brain is of particular interest with regard to disease-causing capacity. Further knowledge of the cellular localization, molecular interactions and qualitative or quantitative differences between RTT-patients and unaffected controls may provide additional insights into the biological functions and clinical relevance of these newly discovered ncRNAs.
###end p 49
###begin p 50
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 112 120 112 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 541 542 541 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B77">77</xref>
Other DNase I hypersensitivity sites have a distribution within MECP2 that varies between different cell lines (Figure 4), suggesting the existence of cell-specific regulatory elements. Similar to the chromatin signature patterns observed at TSSs or TSS clusters, the DNase I hypersensitivity sites located downstream from the major TSS cluster display enrichment for H3ac. However, absence of H3K4me3 or RNA polymerase II enrichment, as well as the presence of H4ac, distinguishes these from the TSS-related DNase I hypersensitivity sites (2,77).
###end p 50
###begin p 51
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B89">89</xref>
###xml 174 179 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK1</italic>
###xml 343 349 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B89">89</xref>
###xml 770 778 770 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
CCCTC-binding factor (CTCF) is a transcription factor known to be required for insulator function (89). A CTCF-binding site is located near the most 5'-terminal of the novel MECP2 transcripts identified by ENCODE, while another is positioned downstream within the IRAK1 gene. Another CTCF-binding site was reported deep within intron 2 by Kim et al. (89) in fibroblasts, and confirmed by the Sanger Institute in a lymphoblastoid cell line (). This intronic CTCF-binding site displays DNaseI hypersensitivity in the lymphoblastoid cell line, as well as in HeLa cells and fibroblasts. Using the HL60 (promyelocyctic leukaemia) cell line, Affymetrix identified another intronic CTCF-binding site that also binds PU1 and the alpha chain of the retinoic acid receptor (RARA; Figure 4; ).
###end p 51
###begin p 52
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 486 491 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 894 899 894 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 225 230 <span type="species:ncbi:9606">human</span>
###xml 867 875 <span type="species:ncbi:9606">patients</span>
While ENCODE has provided a tremendous amount of information concerning potential regulatory elements within MECP2, further work is still needed to meaningfully interpret and integrate these datasets. From the perspective of human disease arising from MECP2 expression abnormalities, which is a predominantly neuronal phenotype, a particular limitation of ENCODE is that chromatin immunoprecipitation results are derived from non-neuronal cell lines. While the mechanisms that regulate MECP2 expression within central nervous system tissues may differ from those in the cell lines represented to date, ENCODE provides a shortlist of candidate regulatory regions. The challenge now is to identify which of these regulatory elements are functional in neuronal cells, and whether any of these can assist in the development of new diagnostic or management strategies for patients with dysregulated MECP2 expression or function.
###end p 52
###begin title 53
CONCLUSION
###end title 53
###begin p 54
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1127 1132 1127 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
Since the discovery that many RTT cases are due to mutations in MECP2, our knowledge of the structure and function of genomic elements within this relatively small gene has advanced significantly. It is now appreciated that MECP2 probably has several biological functions and mechanisms of action, including the recruitment of chromatin-modifying enzymes. Evidence of precise spatial and temporal regulation of an increasing diversity of expression patterns of the two MeCP2 protein isoforms underlines the importance of the emerging details of epigenetic signatures across the MECP2 genomic region. In this regard, it is also interesting to note the numerous recently identified highly conserved non-coding regions, including those within the long 3'-UTR and intron 2. The discovery of transcripts arising from novel intronic exons, as well as from what had been regarded as the upstream intergenic region, is particularly exciting in view of the growing recognition of the existence and functional significance of ncRNAs. Such advances in our understanding of gene biology may aid the process of characterizing precisely how MECP2 dysfunction at the molecular and cellular level leads to neurological phenotypes.
###end p 54
###begin title 55
FUNDING
###end title 55
###begin p 56
Robert Vandongen Vacation Scholarship awarded by the Royal Perth Hospital Medical Research Foundation to J.S. A.S. is supported by an NH & MRC Biomedical postdoctoral fellowship 404132.
###end p 56
###begin p 57
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 57
###begin title 58
ACKNOWLEDGEMENTS
###end title 58
###begin p 59
We would like to thank Paula Moolhuijzen, Dr David S Dunn and Professor Matthew Bellgard of the Centre of Comparative Genomics at Murdoch University for offering their bioinformatic expertise and the use of their resources. We appreciate also the helpful critical comments from an anonymous reviewer.
###end p 59
###begin title 60
REFERENCES
###end title 60
###begin article-title 61
Non-coding RNA. Hum.
###end article-title 61
###begin article-title 62
###xml 64 69 <span type="species:ncbi:9606">human</span>
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project
###end article-title 62
###begin article-title 63
What is a gene, post-ENCODE? History and updated definition
###end article-title 63
###begin article-title 64
Origin of phenotypes: genes and transcripts
###end article-title 64
###begin article-title 65
Genetic control of biochemical reactions in neurospora
###end article-title 65
###begin article-title 66
Genome-wide transcription and the implications for genomic organization
###end article-title 66
###begin article-title 67
###xml 27 32 <span type="species:ncbi:9606">human</span>
Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution
###end article-title 67
###begin article-title 68
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human genome browser at UCSC
###end article-title 68
###begin article-title 69
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced
###end article-title 69
###begin article-title 70
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions
###end article-title 70
###begin article-title 71
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
The X-linked methylated DNA binding protein, Mecp2, is subject to X inactivation in the mouse
###end article-title 71
###begin article-title 72
###xml 67 72 <span type="species:ncbi:9606">human</span>
Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2
###end article-title 72
###begin article-title 73
X-inactivation profile reveals extensive variability in X-linked gene expression in females
###end article-title 73
###begin article-title 74
A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3''-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression
###end article-title 74
###begin article-title 75
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
Distinct expression profiles of Mecp2 transcripts with different lengths of 3'UTR in the brain and visceral organs during mouse development
###end article-title 75
###begin article-title 76
Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA
###end article-title 76
###begin article-title 77
Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA
###end article-title 77
###begin article-title 78
Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2
###end article-title 78
###begin article-title 79
###xml 49 55 <span type="species:ncbi:10090">murine</span>
###xml 60 65 <span type="species:ncbi:9606">human</span>
Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes
###end article-title 79
###begin article-title 80
Comparative study of methyl-CpG-binding domain proteins
###end article-title 80
###begin article-title 81
DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG
###end article-title 81
###begin article-title 82
DNA methylation patterns and epigenetic memory
###end article-title 82
###begin article-title 83
DNA methylation specifies chromosomal localization of MeCP2
###end article-title 83
###begin article-title 84
MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin
###end article-title 84
###begin article-title 85
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
###end article-title 85
###begin article-title 86
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
###end article-title 86
###begin article-title 87
The Ski protein family is required for MeCP2-mediated transcriptional repression
###end article-title 87
###begin article-title 88
MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery
###end article-title 88
###begin article-title 89
The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation
###end article-title 89
###begin article-title 90
Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing
###end article-title 90
###begin article-title 91
Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation
###end article-title 91
###begin article-title 92
MeCP2 preferentially binds to methylated linker DNA in the absence of the terminal tail of histone H3 and independently of histone acetylation
###end article-title 92
###begin article-title 93
###xml 24 29 <span type="species:ncbi:9606">human</span>
Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation
###end article-title 93
###begin article-title 94
Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin
###end article-title 94
###begin article-title 95
MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome
###end article-title 95
###begin article-title 96
Structure-specific binding of MeCP2 to four-way junction DNA through its methyl CpG-binding domain
###end article-title 96
###begin article-title 97
Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo
###end article-title 97
###begin article-title 98
Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome
###end article-title 98
###begin article-title 99
DLX5 and DLX6 expression is biallelic and not modulated by MeCP2 deficiency
###end article-title 99
###begin article-title 100
Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes
###end article-title 100
###begin article-title 101
MeCP2, a key contributor to neurological disease, activates and represses transcription
###end article-title 101
###begin article-title 102
Components of the DNA methylation system of chromatin control are RNA-binding proteins
###end article-title 102
###begin article-title 103
Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2
###end article-title 103
###begin article-title 104
Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2
###end article-title 104
###begin article-title 105
Multiple pathways regulate MeCP2 expression in nomal brain development and exhibit defects in autism spectrum disorders
###end article-title 105
###begin article-title 106
Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation
###end article-title 106
###begin article-title 107
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Mild overexpression of MeCP2 causes a progressive neurological disorder in mice
###end article-title 107
###begin article-title 108
Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28
###end article-title 108
###begin article-title 109
Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons
###end article-title 109
###begin article-title 110
###xml 123 127 <span type="species:ncbi:10090">mice</span>
Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice
###end article-title 110
###begin article-title 111
###xml 40 44 <span type="species:ncbi:10090">mice</span>
The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression
###end article-title 111
###begin article-title 112
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2
###end article-title 112
###begin article-title 113
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 119 126 <span type="species:ncbi:8355">Xenopus</span>
A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos
###end article-title 113
###begin article-title 114
MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions
###end article-title 114
###begin article-title 115
A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome
###end article-title 115
###begin article-title 116
The major form of MeCP2 has a novel N-terminus generated by alternative splicing
###end article-title 116
###begin article-title 117
Lost in translation: translational interference from a recurrent mutation in exon 1 of MECP2
###end article-title 117
###begin article-title 118
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Differential distribution of the MeCP2 splice variants in the postnatal mouse brain
###end article-title 118
###begin article-title 119
MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation
###end article-title 119
###begin article-title 120
Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1
###end article-title 120
###begin article-title 121
###xml 78 83 <span type="species:ncbi:9606">human</span>
Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated
###end article-title 121
###begin article-title 122
The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA
###end article-title 122
###begin article-title 123
A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome
###end article-title 123
###begin article-title 124
Characterization of a novel protein-binding module-the WW domain
###end article-title 124
###begin article-title 125
Structural basis for APPTPPPLPP peptide recognition by the FBP11WW1 domain
###end article-title 125
###begin article-title 126
Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation
###end article-title 126
###begin article-title 127
Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders
###end article-title 127
###begin article-title 128
###xml 78 83 <span type="species:ncbi:9606">human</span>
Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation
###end article-title 128
###begin article-title 129
Dissecting MECP2 function in the central nervous system
###end article-title 129
###begin article-title 130
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Reversal of neurological defects in a mouse model of Rett syndrome
###end article-title 130
###begin article-title 131
Identification of cis-regulatory elements for MECP2 expression
###end article-title 131
###begin article-title 132
Genome-wide analysis of mammalian promoter architecture and evolution
###end article-title 132
###begin article-title 133
Mammalian RNA polymerase II core promoters: insights from genome-wide studies
###end article-title 133
###begin article-title 134
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 77 82 <span type="species:ncbi:9606">human</span>
The landscape of histone modifications across 1% of the human genome in five human cell lines
###end article-title 134
###begin article-title 135
Diversity of cytoplasmic functions for the 3' untranslated region of eukaryotic transcripts
###end article-title 135
###begin article-title 136
###xml 88 93 <span type="species:ncbi:9606">human</span>
Analyses of deep mammalian sequence alignments and constraint predictions for 1% of the human genome
###end article-title 136
###begin article-title 137
AU-rich elements: characterization and importance in mRNA degradation
###end article-title 137
###begin article-title 138
Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA
###end article-title 138
###begin article-title 139
Prominent use of distal 5' transcription start sites and discovery of a large number of additional exons in ENCODE regions
###end article-title 139
###begin article-title 140
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs
###end article-title 140
###begin article-title 141
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Specific expression of long noncoding RNAs in the mouse brain
###end article-title 141
###begin article-title 142
Long, abundantly expressed non-coding transcripts are altered in cancer
###end article-title 142
###begin article-title 143
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome
###end article-title 143
###begin article-title 144
###xml 39 44 <span type="species:ncbi:9606">human</span>
Identification and characterization of human non-coding RNAs with tissue-specific expression
###end article-title 144
###begin article-title 145
###xml 71 76 <span type="species:ncbi:9606">human</span>
Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome
###end article-title 145
###begin article-title 146
DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation
###end article-title 146
###begin article-title 147
###xml 74 82 <span type="species:ncbi:9606">patients</span>
The impact of MECP2 mutations in the expression patterns of Rett syndrome patients
###end article-title 147
###begin article-title 148
Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3
###end article-title 148
###begin article-title 149
MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression
###end article-title 149
###begin article-title 150
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome
###end article-title 150
###begin article-title 151
Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome
###end article-title 151
###begin article-title 152
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome
###end article-title 152
###begin article-title 153
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
###xml 149 154 <span type="species:ncbi:9606">human</span>
Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains
###end article-title 153
###begin article-title 154
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice
###end article-title 154
###begin article-title 155
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets
###end article-title 155
###begin article-title 156
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Ube3a expression is not altered in Mecp2 mutant mice
###end article-title 156

